WO2023103772A1 - Solid tumor tracing device - Google Patents

Solid tumor tracing device Download PDF

Info

Publication number
WO2023103772A1
WO2023103772A1 PCT/CN2022/133695 CN2022133695W WO2023103772A1 WO 2023103772 A1 WO2023103772 A1 WO 2023103772A1 CN 2022133695 W CN2022133695 W CN 2022133695W WO 2023103772 A1 WO2023103772 A1 WO 2023103772A1
Authority
WO
WIPO (PCT)
Prior art keywords
light
solid tumor
displacement mechanism
optical
carrier
Prior art date
Application number
PCT/CN2022/133695
Other languages
French (fr)
Chinese (zh)
Inventor
周星
Original Assignee
周星
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 周星 filed Critical 周星
Publication of WO2023103772A1 publication Critical patent/WO2023103772A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925Markers, e.g. radio-opaque or breast lesions markers ultrasonic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3937Visible markers
    • A61B2090/3941Photoluminescent markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3954Markers, e.g. radio-opaque or breast lesions markers magnetic, e.g. NMR or MRI
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3966Radiopaque markers visible in an X-ray image

Definitions

  • the invention relates to a medical tracing system, in particular to a solid tumor tracing device.
  • tumor tissues can be found in very small volumes, such as lung nodules, uterine fibroids, esophageal tumors, and liver tumors. Due to the small size of these tumor tissues, such as pulmonary nodules, it is difficult to accurately identify them during laparoscopic resection. Therefore, it is necessary to mark the tumor tissues that need to be removed to facilitate surgical resection under laparoscope.
  • the current calibration of small-volume tumor tissue is usually carried out by placing marking mechanisms such as positioning hooks in the X-ray environment, and then leaving the positioning hooks and other marking mechanisms at the tumor tissue. During the operation, the position of the marking mechanism is identified. Operation.
  • the marking mechanism is usually small in size and is easy to develop in X-ray and other environments, it is often difficult to identify the marking mechanism under the endoscope and during the operation due to the interference of blood, etc., resulting in It is difficult to accurately determine the location of the tumor.
  • the invention discloses a tumor tissue based on visible light technology, especially a calibration technology and device for solid tumors.
  • the purpose of the present invention is to solve the problem that the location of small-volume tumor tissue or solid tumor tissue cannot be accurately identified in the existing clinical operation.
  • the tumor tissue that needs to be removed during the operation is convenient for surgical resection of the tumor tissue under the laparoscope.
  • the solid tumor tracking device of the present invention is characterized in that: the solid tumor tracking device 910 includes a medical optical tracking system 500; Solid tumors were identified by location.
  • the medical optical tracer system 500 can emit visible light under the action of the optical tracer carrier 2.
  • solid tumors can be quickly and effectively identified and resected by the prompt of visible light. .
  • the solid tumor tracking device 910 includes a developing mechanism 4 .
  • the development mechanism 4 can provide development prompts in X-ray, magnetic navigation, or B-ultrasound scenarios, which facilitates the placement of the solid tumor tracking device 910 .
  • the solid tumor tracking device 910 includes an anti-displacement mechanism 910-1.
  • the anti-displacement mechanism 910-1 can be fixed on the solid tumor that needs to be calibrated, so as to prevent the solid tumor tracking device 910 from moving with the movement of the human body, such as lung breathing movement, intestinal peristalsis, gastric peristalsis, etc. shift.
  • the solid tumor tracking device 910 includes a delivery mechanism 910-2.
  • the delivery mechanism 910-2 can deliver the anti-displacement mechanism 910-1 to a solid tumor that needs to be marked.
  • the delivery mechanism 910-2 delivers the anti-displacement mechanism 910-1 to the position of the solid tumor under X-ray or MRI conditions, and fixes it on the solid tumor.
  • the carrier 2 is arranged on the anti-displacement mechanism 910-1. By positioning the anti-displacement mechanism 910-1, the position of the solid tumor can be visually observed with the naked eye under the guidance of the light during the operation.
  • the anti-displacement mechanism 910-1 has a hook-shaped structure, and/or a trumpet-shaped structure, and/or a dumbbell-shaped structure, and/or a coil spring-shaped structure, and/or a nail-shaped structure in a working state.
  • the applicant here only exemplifies the manners of the anti-displacement mechanism 910-1 with the above-mentioned several structures. In practical applications, those skilled in the art can design the anti-displacement mechanism 910-1 with different structures as required 1. The applicant does not give examples one by one here, but they all do not depart from the protection scope of the present application.
  • the anti-displacement mechanism 910-1 has a hook-like structure and includes at least one positioning hook 910-11.
  • the anti-displacement mechanism 910-1 includes two positioning hooks 910-11. Usually, the anti-displacement mechanism 910-1 includes 2 or 3 positioning hooks 910-11 to better prevent the anti-displacement mechanism 910-1 from moving with the human body, such as the breathing of the lungs. Displacement occurs due to movement, intestinal peristalsis, etc.
  • the anti-displacement mechanism 910-1 is made of shape memory alloy, and has a linear structure outside the body, and returns to the set hook structure, and/or horn-shaped structure, and/or dumbbell after entering the human body under the action of body temperature Type structure, and/or helical spring type structure, and/or nail-like structure.
  • the anti-displacement mechanism 910-1 is made of developing material, which constitutes the developing mechanism 4, and develops under X-ray and/or MRI and/or B-ultrasound. In clinical use, under X-ray, and/or MRI, and/or B-ultrasound, the anti-displacement mechanism 910-1 is placed in the tumor tissue that needs to be marked.
  • the delivery mechanism 910-2 includes a push mechanism 910-21 and a delivery sheath 910-22.
  • the anti-displacement mechanism 910-1 is set in the delivery sheath 910-22, and the pushing mechanism 910-21 can push the anti-displacement mechanism 910-1 out of the delivery sheath 910-22. Launched into solid tumors.
  • the pushing mechanism 910-22 can be fixedly connected with the anti-displacement mechanism 910-1, and stay in the body together after the anti-displacement mechanism 910-1 is pushed out from the delivery sheath 910-21;
  • the mechanism 910-22 can also be detachably connected with the anti-displacement mechanism 910-1, after the anti-displacement mechanism 910-1 is pushed out from the delivery sheath 910-21, and the anti-displacement mechanism 910 - 1 Disconnect, and only place the anti-displacement mechanism 910-1 on the solid tumor.
  • the medical optical tracer system 500 includes a light source 1 and an optical tracer carrier 2;
  • the optical trace carrier 2 contains a light-guiding material
  • the light emitted by the light source 1 is transmitted through the optical trace carrier 2, and the optical trace carrier 2 is optically traced.
  • the optical tracking carrier 2 can perform optical tracking on the displacement mechanism 910-1.
  • the light source 1 is an LED light source 11, and/or a medical cold light source 12, and/or natural light.
  • the light source 1 can be various light sources capable of emitting light, and the light emitted by the light source 1 can be traced after being transmitted through the optical trace carrier 1 .
  • the LED light source 11 has the characteristics of small size, high luminous efficiency, and strong light source directivity. Especially in terms of safety, LED light sources have incomparable advantages over ordinary light sources.
  • the LED light source is a low-voltage DC power supply, and the power supply voltage only needs to be 6 to 24V; secondly, no mercury is added to the LED light source, which will not cause poisoning or other harm to the human body; more importantly, the LED light source is a cold light source, which will not cause harm to the human body during work. Severe heat, safe to touch, will not cause unexpected high temperature burns to the human body.
  • the medical cold light source 12 is a commonly used light source in the existing operation process, and the light source 1 can be placed behind, which is easy to obtain in the operating room and does not require additional equipment.
  • the color of light emitted by the light source 1 can be set according to background color or penetration requirements. Through the setting of the light, in the clinical operation, the doctor can directly see the position of the optical tracer 2 through the tissue with the naked eye, and then accurately identify the blood vessels, tissues or organs that need to be protected during the clinical operation, effectively avoiding Accidental injury during surgery.
  • the light emitted by the light source 1 can be differentiated according to the background color in the body cavity or the tissue to be penetrated. When the tissue needs to be penetrated, red and yellow are the best, followed by purple and white.
  • the light source 1 is a flashing type of light emitting.
  • the light source 1 can also be set in the form of intermittent lighting, flashing, etc. as required.
  • the intensity of light emitted by the light source 1 can be set.
  • the intensity of the light emitted by the light source 1 can also be adjusted as required to adapt to different clinical environments.
  • the illuminance of the light emitted by the light source 1 can reach 300,000 lux, preferably ranging from 5,000 lux to 150,000 lux.
  • the light source 1 includes a control system 13, the control system 13 includes a wavelength adjustment mechanism 13-1 and a light intensity adjustment mechanism 13-2, and the wavelength adjustment mechanism 13-1 can adjust the color of the emitted light by adjusting the wavelength , the light intensity adjusting mechanism 13-2 can adjust the illuminance of the emitted light.
  • the LED light source 11 is arranged inside the body and/or outside the body. Since the volume of the light-emitting end 11-1 of the LED light source 11 can be very small, the LED light source 11 can not only be installed outside the body, and transmit light to the human body through the optical tracer carrier 2, but also can be directly installed In the human body, the optical tracking carrier 2 is coated on the outside and placed directly on the part that needs to be tracked.
  • the optical tracer 2 is a light-storage self-luminous tracer 21 .
  • Self-luminous materials refer to materials that can absorb energy in a certain way and convert it into non-equilibrium light radiation. The process of converting the energy absorbed inside the material into non-equilibrium light radiation is the luminescence process.
  • light-storing self-luminescent materials can continue to emit light for more than 12 hours in a dark environment after a few minutes or tens of minutes under the action of external light, which can meet the tracing needs of most operations.
  • the light-storing self-illuminating tracer carrier 21 can directly absorb the energy of the light in the operating room, so that various external lights can form the light source 1, and there is no need to directly connect the light source 1, and the use process is very simple.
  • the light-storage self-luminous tracer carrier 21 includes a light-storage self-illuminator 21-1 and a protection carrier 21-2.
  • the protective carrier 21-2 is made of a transparent light-guiding material, and the light-storing self-luminous body 21-1 is closed and arranged in the protective carrier 21-2.
  • the light-storing self-luminous body 21-1 can absorb external energy and convert it into light.
  • the protective carrier 21-2 is made of transparent medical materials, which can be directly in contact with tissues.
  • the light energy converted from the light-storing self-illuminating body 21-1 effectively passes through for effective tracing, and at the same time ensures clinical Biosafety used.
  • the light-storing self-illuminating body 21-1 can be arranged in different positions and designed in different shapes, and can perform fixed-point tracking or overall tracking as required.
  • the optical trace carrier 2 is a light guiding fiber 22 .
  • the light-guiding optical fiber 22 has a good light-guiding effect, and guides the light to different positions as required, and can be switched on or off as required, which is very convenient for clinical use.
  • the light guiding fiber 22 has a non-smooth surface 22-1.
  • the non-smooth surface 22-1 is a non-smooth surface 22-11 capable of forming reflection and/or scattering.
  • the non-smooth surface 22-1 can realize the overall light emission of the non-smooth surface 22-1 through the reflection and/or scattering of light, so as to achieve the effect of overall tracking.
  • the light-guiding optical fiber 22 is intermittently provided with a light outlet 22-2.
  • Each of the light outlets 22-2 provided intermittently has a light transmission surface 22-21 and a reflection surface 22-22, the light is transmitted through the transmission surface 22-21, and when it reaches the reflection surface 22-22, The light is reflected and emitted from the light outlet 22-2 to form a tracer point, and a plurality of the light outlets 22-2 can form a chain tracer strip.
  • the light-guiding optical fiber 22 is braided into a net shape, and light outlets 22-2 are scattered in different positions.
  • the light-guiding optical fiber 22 is braided into a net shape, and the length of each of the light-guiding optical fibers 22 can be set to be different, and the light outlets 22-2 of the light-guiding optical fiber 22 are also different thereupon, scattered and distributed, which can be To realize the overall tracking in the three-dimensional space, since the light outlet 22-1 does not need to be arranged in the middle of each light-guiding optical fiber 22, the light transmission effect is better, and the visual effect of a single tracking point is very bright. It is also possible to weave the light-guiding optical fiber 22 that is provided with the light outlet 22-2 on the side and can be illuminated as a whole into a net shape, so as to realize full-area tracking of the entire anti-displacement mechanism 910-1.
  • the surface of the light guiding fiber 22 contains a coating 3 .
  • the coating 3 can be designed with different properties as required, such as anticoagulation coating, hydrophilic coating or hydrophobic coating.
  • the optical trace carrier 2 is provided with a developing mechanism 4, and the developing mechanism 4 performs developing under X-ray, and/or MRI, and/or B-ultrasound.
  • the developing mechanism 4 may be a developing line, and/or a developing ring, and/or a developing block and the like.
  • the applicant here only exemplifies the above-mentioned several developing methods. In practical applications, those skilled in the art can design different developing methods according to needs. The applicant does not give examples here, but they do not deviate from the scope of the application protected range.
  • the development mechanism 4 can perform development prompts in X-ray, magnetic navigation, or B-ultrasound scenarios, and the development mechanism 4 facilitates the optical tracking carrier 2 to be placed into the tumor tissue under the condition of visualization or navigation Inside.
  • the optical trace carrier 2 is made of flexible medical material, and is arranged on the outer surface of the anti-displacement mechanism 910-1.
  • the optical tracer carrier 2 is a light guide fiber 22, the proximal end of the light guide fiber 22 is connected to the light guide joint 26, and the far end of the light guide fiber 22 is connected and fixed on the anti-displacement mechanism 910- 1, the light outlet 22-2 of the light guide fiber 22 is set on the anti-displacement mechanism 910-1, and traces the anti-displacement mechanism 910-1.
  • the light guiding fiber 22 has a non-smooth surface 22-1, and the side of the light guiding fiber 22 is provided with a light outlet 22-2, and the light guiding fiber 22 is an overall display of the anti-displacement mechanism 910-1. trace.
  • the light guiding fiber 22 is made of flexible medical materials, and is connected and fixed on the anti-displacement mechanism 910-1. When the anti-displacement mechanism 910-1 is deformed, the light guiding fiber 22 follows the The anti-displacement mechanism 910-1 is deformed.
  • the light guiding fiber 22 can be lighted as a whole, winding the light guiding fiber 22 on the anti-displacement mechanism 910-1, especially on the positioning hook 910-11, can follow the The anti-displacement mechanism 910-1 is deformed together, especially when the anti-displacement mechanism 910-1 is made of shape memory alloy, as the shape of the anti-displacement mechanism 910-1 changes, the guide The shape of the optical fiber 22 also changes accordingly to ensure the tracking effect of the anti-displacement mechanism 910-1.
  • the light source 1 of the medical optical tracer system 500 is an LED light source 11, the optical tracer carrier 2 is made of a transparent material, and the light-emitting end 11-1 of the LED light source 11 is set on the optical tracer carrier 2 , set on or on the anti-displacement mechanism 910-1 together with the optical trace carrier 2, and trace the anti-displacement mechanism 910-1.
  • the light-emitting end 11-1 of the LED light source 11 can be packaged with the optical trace carrier 2 as a whole, and they are jointly arranged on the anti-displacement mechanism 910-1.
  • the light emitted by the light-emitting end 11-1 is displayed after being transmitted through the light-guiding material of the optical tracer carrier 2, for clinically identifying the location of the solid tumor.
  • the LED light source 11 includes a light-emitting terminal 11-1, a circuit system 11-2, a drive board 11-3, and a power supply 11-4; the light-emitting terminal 11-1 passes through the circuit system 11-2 and the drive board 11 -3 and the power supply 11-4 are connected, and under the control of the driving board 11-3, the power supply 11-4 supplies power to the light emitting terminal 11-1 through the circuit system 11-2, and the light emitting The end 11-1 emits light; the driving board 11-3 and the power supply 11-4 are arranged outside the body, and the light emitting end 11-1 is arranged inside the body to trace the anti-displacement mechanism 910-1.
  • the circuit system 11-2 is a flexible circuit board 11-21, and the light emitting ends 11-1 of the LED light source 11 are dispersedly arranged on the flexible circuit board 11-21 and packaged in the optical tracer carrier 2, It constitutes an LED light strip, or an LED light net, or an LED light ball, and is arranged on the anti-displacement mechanism 910-1 to track the anti-displacement mechanism 910-1.
  • the LED light source 11 can be packaged with a single light-emitting terminal 11-1 for fixed-point tracking. It is also possible to use a flexible circuit board 11-21 for the circuit system 11-2, and the light-emitting ends 11-1 are dispersedly arranged at any position of the flexible circuit board 11-21, thereby forming a light-emitting strip, and the light-emitting strip Winding on the anti-displacement mechanism 910-1, or packaging multiple LED light sources 11 together with the optical tracer carrier 2 into a net shape, spherical shape, etc., the anti-displacement mechanism 910-1 Carry out overall tracing.
  • the light-emitting end 11-1 of the LED light source 11 is arranged on the anti-displacement mechanism 910-1, and the outside is coated with the optical tracer carrier 2 made of transparent material, and the light emitted by the light-emitting end 11-1
  • the anti-displacement mechanism 910-1 is traced.
  • the light-emitting ends 11-1 are dispersedly arranged on the anti-displacement mechanism 910-1, and trace the entire anti-displacement mechanism (910-1).
  • the light-emitting end 11-1 can be directly arranged on the anti-displacement mechanism 910-1, and then the optical tracer carrier 2 made of transparent material is coated on the outside, so that the light-emitting end 11-1 can be completely It fits the outer contour of the anti-displacement mechanism 910-1 accurately, and traces any shape of the anti-displacement mechanism 910-1.
  • the light-emitting end 11-1 is arranged symmetrically, and the outside covers the optical tracer carrier 2, and the internal support of the light-emitting end 11-1 and the circuit system 11-2 and the light-emitting end 11-1 Its own volume can constitute the anti-displacement mechanism 910-1, and the medical optical tracking system 500 can simultaneously have the tracking function and the positioning function of the anti-displacement mechanism 910-1.
  • the circuit system 11-2 is a flexible circuit board 11-21
  • the optical trace carrier 2 is made of soft transparent material
  • the light-emitting terminal 11-1, the flexible circuit board 11-21 and the developing mechanism 4 They are arranged together in the optical trace carrier 2 and on the anti-displacement mechanism 910-1.
  • the anti-displacement mechanism 910-1 is deformed, the light-emitting end 11-1, the The flexible circuit board 11 - 21 , the developing mechanism 4 and the optical trace carrier 2 are deformed together with the anti-displacement mechanism 910 - 1 .
  • the anti-displacement mechanism 910-1 is made of shape memory alloy, as the shape of the anti-displacement mechanism 910-1 changes, the shape of the flexible circuit board 11-21 also changes accordingly. , to ensure the tracking effect on the anti-displacement mechanism 910-1.
  • the anti-displacement mechanism 910-1 is set in the delivery sheath 910-21, and under X-ray or MRI conditions, the delivery sheath 910-21 is inserted into the position of the solid tumor, and then the delivery sheath 910-21 is used to The pushing mechanism 910-22 pushes out the anti-displacement mechanism 910-1 and fixes it on the solid tumor, and then removes the delivery sheath 910-21 to stop and fix the anti-displacement mechanism 910-1 on the solid tumor
  • the light source 1 is turned on, and the optical tracer traces the anti-displacement mechanism 910-1, so that the position of the solid tumor can be visually observed with the naked eye under the guidance of the light. .
  • the solid tumor tracking device of the present invention includes an anti-displacement mechanism 910-1, a delivery mechanism 910-2, a developing mechanism 4, and a medical optical tracing system 500; the medical optical tracing system 500 controls the displacement preventing mechanism 910 -1 for optical tracing.
  • the medical optical tracer system 500 includes a light source 1 and an optical tracer carrier 2 . After the light emitted by the light source 1 is transmitted through the optical trace carrier 2, the optical trace carrier 2 is optically traced.
  • the light source 1 can also use the miniature LED light source 11, and the light-emitting end 11-1 of the LED light source 11 is directly arranged with the optical tracer carrier 2 as a whole and put into the human body for optical tracer.
  • the solid tumor tracer device of the present invention can trace solid tumors through visible light after entering the human body.
  • the light source 1 is turned on, and the optical tracer
  • the carrier 2 traces the anti-displacement mechanism 910-1, so that the position of the solid tumor can be visually observed with the naked eye under the guidance of the light, and the clinical operation is safer and more convenient.
  • FIG. 1 is a three-dimensional structural schematic diagram of a solid tumor tracking device of the present invention with a positioning hook housed in a delivery sheath.
  • Fig. 1-1 is a sectional view of A-A in Fig. 1 .
  • Figure 1-2 is an enlarged view of A1 in Figure 1.
  • Fig. 2 is a schematic diagram of the structure when the positioning hook of Fig. 1 is pushed out.
  • Fig. 2-1 is a B-B sectional view of Fig. 2 .
  • Figure 2-2 is an enlarged view of B1 in Figure 2.
  • Figure 2-3 is an enlarged view of B2 in Figure 2-2.
  • Figures 2-4 are exploded views of Figure 2.
  • Fig. 3 is a schematic diagram of the structure in which the light-emitting end of the LED light source is arranged on the positioning hook.
  • Figure 3-1 is an enlarged view of C1 in Figure 3.
  • Fig. 4 is a schematic structural view of the solid tumor tracking device of the present invention with an interrupted open sleeve.
  • Figure 4-1 is an enlarged view of D1 in Figure 4.
  • Fig. 5 is a schematic structural diagram of a tracking device containing multiple solid tumors.
  • Figure 5-1 is an exploded view of Figure 5.
  • Fig. 6 is a schematic structural view of the solid tumor tracking device of the present invention with a spherical anti-displacement mechanism.
  • Fig. 6-1 is a sectional view along line E-E of Fig. 6 .
  • Figure 6-2 is an enlarged view of E1 in Figure 6-1.
  • Fig. 7 is a schematic structural view of the solid tumor tracking device of the present invention with a dumbbell-shaped anti-displacement mechanism.
  • Figure 7-1 is an enlarged view of F1 in Figure 7.
  • Fig. 7-2 is a sectional view of F-F in Fig. 7 .
  • Figure 7-3 is an enlarged view of F2 in Figure 7-2.
  • Figure 7-4 is a coated dumbbell-shaped anti-displacement mechanism.
  • Fig. 8 is a schematic structural view of the solid tumor tracking device of the present invention with a helical anti-displacement mechanism.
  • Figure 8-1 is an enlarged view of G1 in Figure 8.
  • Fig. 9 is a schematic structural view of the solid tumor tracking device of the present invention which includes both a helical constant and a dumbbell-shaped anti-displacement mechanism.
  • Figure 9-1 is an enlarged view of H1 in Figure 9.
  • Fig. 10 is a schematic structural view of a solid tumor tracking device of the present invention including an LED light source.
  • Fig. 10-1 is a schematic structural view of the delivery mechanism in Fig. 10 after being removed.
  • Fig. 11 is a schematic structural diagram of a solid tumor tracking device of the present invention including a medical cold light source.
  • Fig. 12 is a schematic structural diagram of a solid tumor tracking device of the present invention containing a light-storing self-luminescent tracking carrier.
  • Figure 12-1 is an enlarged view of I1 in Figure 12.
  • Fig. 13 is a schematic diagram of the working principle of the solid tumor tracking device of the present invention when it is inserted into a pulmonary nodule.
  • Fig. 13-1 is a working principle diagram of Fig. 13 after the delivery mechanism is removed and the light-guiding fiber is connected to the light source.
  • 500 is a medical optical tracing system
  • 910 is a solid tumor tracing device of the present invention.
  • 1 is a light source
  • 2 is an optical tracer carrier
  • 3 is a coating
  • 4 is a developing mechanism
  • 5 is a protective sleeve.
  • 11 is the LED light source
  • 12 is the medical cold light source
  • 13 is the control system
  • 11-1 is the light-emitting terminal
  • 11-2 is the circuit system
  • 11-3 is the drive board
  • 11-4 is the power supply
  • 13-1 is the wavelength adjustment mechanism
  • 13-2 is a light intensity adjustment mechanism
  • 11-21 is a flexible circuit board.
  • 21 is a light-storage self-illumination tracer carrier, 22 is a light-guiding optical fiber, and 26 is a light-guiding joint; 21-1 is a light-storage self-illumination body, and 21-2 is a protection carrier; 22-1 is a non-smooth surface, and 22-2 is a Light outlet: 22-11 is a non-smooth surface capable of forming reflection and/or scattering, 22-21 is a conductive surface, and 22-22 is a reflective surface.
  • 910-1 is an anti-displacement mechanism
  • 910-2 is a delivery mechanism
  • 910-11 is a positioning hook
  • 910-21 is a delivery sheath
  • 910-22 is a pushing mechanism.
  • Embodiment 1 The solid tumor tracking device of the present invention
  • the anti-displacement mechanism 910-1 performs optical tracking.
  • the anti-displacement mechanism 910-1 can be fixed on the solid tumor that needs to be calibrated, so as to prevent the solid tumor tracking device 910 from moving with the movement of the human body, such as lung breathing movement, intestinal peristalsis, gastric peristalsis, etc. shift.
  • the color of light emitted by the light source 1 can be set according to background color or penetration requirements. Through the setting of light, in clinical operations, doctors can directly see the position of the optical tracer carrier 2 through the tissue with the naked eye, and then accurately identify the blood vessels, tissues or organs that need to be protected during clinical operations, effectively avoiding Accidental injury during surgery.
  • the light emitted by the light source 1 can be differentiated according to the background color in the body cavity or the tissue to be penetrated. When the tissue needs to be penetrated, red and yellow are the best, followed by purple and white.
  • the light source 1 is a flashing type of light emitting.
  • the light source 1 can also be set to intermittent lighting, flashing, etc. as required.
  • the intensity of light emitted by the light source 1 can be set.
  • the intensity of the light emitted by the light source 1 can also be adjusted as required to adapt to different clinical environments.
  • the illuminance of the light emitted by the light source 1 can reach 300,000 lux, preferably ranging from 5,000 lux to 150,000 lux.
  • the light source 1 includes a control system 13, the control system 13 includes a wavelength adjustment mechanism 13-1 and a light intensity adjustment mechanism 13-2, and the wavelength adjustment mechanism 13-1 can adjust the wavelength To adjust the color of the emitted light, the light intensity adjustment mechanism 13-2 can adjust the illuminance of the emitted light.
  • the anti-displacement mechanism 910-1 is in a hook-shaped structure in working state, and includes two positioning hooks 910-11.
  • the anti-displacement mechanism 910-1 includes 2 or 3 positioning hooks 910-11 to better prevent the anti-displacement mechanism 910-1 from moving with the human body, such as the breathing of the lungs. Displacement occurs due to movement, intestinal peristalsis, etc.
  • the anti-displacement mechanism 910-1 can also be a spherical structure (refer to FIG. 6 to FIG. 6-2 ), a horn-shaped structure, and/or a dumbbell-shaped structure (refer to FIG. 7 to FIG. 3, Figure 9 and Figure 9-1), and/or a helical spring structure (refer to Figure 8 and Figure 8-1, Figure 9 and Figure 9-1), and/or a nail-like structure.
  • the applicant here only exemplifies the manners of the anti-displacement mechanism 910-1 with the above-mentioned several structures. In practical applications, those skilled in the art can design the anti-displacement mechanism 910-1 with different structures as required 1. The applicant does not give examples one by one here, but they all do not depart from the protection scope of the present application.
  • the anti-displacement mechanism 910-1 can be made of shape memory alloy, which has a linear structure outside the body, and returns to the set hook-shaped structure and/or trumpet-shaped structure under the action of body temperature after entering the human body, and/or A dumbbell-shaped structure, and/or a helical spring-shaped structure, and/or a spike-shaped structure.
  • the anti-displacement mechanism 910-1 is made of a developing material, which constitutes the developing mechanism 4, and develops under X-ray and/or MRI and/or B-ultrasound. In clinical use, under X-ray, and/or MRI, and/or B-ultrasound, the anti-displacement mechanism 910-1 is placed in the tumor tissue that needs to be marked.
  • the delivery mechanism 910-2 includes a push mechanism 910-21 and a delivery sheath 910-22.
  • the anti-displacement mechanism 910-1 is set in the delivery sheath 910-22, and the pushing mechanism 910-21 can push the anti-displacement mechanism 910-1 from The delivery sheath 910-22 is pushed out and placed into a solid tumor.
  • the pushing mechanism 910-22 can be fixedly connected with the anti-displacement mechanism 910-1, and stay in the body together after the anti-displacement mechanism 910-1 is pushed out from the delivery sheath 910-21;
  • the mechanism 910-22 can also be detachably connected with the anti-displacement mechanism 910-1, after the anti-displacement mechanism 910-1 is pushed out from the delivery sheath 910-21, and the anti-displacement mechanism 910 - 1 Disconnect, and only place the anti-displacement mechanism 910-1 on the solid tumor.
  • the medical optical tracer system 500 includes a light source 1 and an optical tracer carrier 2 .
  • the optical tracer carrier 2 contains a light-guiding material, and the light emitted by the light source 1 is conducted through the optical tracer carrier 2 and optically traces the optical tracer carrier 2 .
  • the optical tracking carrier 2 can perform optical tracking on the displacement mechanism 910-1.
  • the light source 1 may be an LED light source 11, and/or a medical cold light source 12, and/or natural light.
  • the light source 1 can be various light sources capable of emitting light, and the light emitted by the light source 1 can be traced after being transmitted through the optical trace carrier 1 .
  • the LED light source 11 has the characteristics of small size, high luminous efficiency, and strong light source directivity. Especially in terms of safety, LED light sources have incomparable advantages over ordinary light sources.
  • the LED light source is a low-voltage DC power supply, and the power supply voltage only needs to be 6 to 24V; secondly, no mercury is added to the LED light source, which will not cause poisoning or other harm to the human body; more importantly, the LED light source is a cold light source, which will not cause harm to the human body during work. Severe heat, safe to touch, will not cause unexpected high temperature burns to the human body.
  • the medical cold light source 12 is a commonly used light source in the existing operation process, and the light source 1 can be placed behind, which is easy to obtain in the operating room and does not require additional equipment.
  • the light source 1 is the LED light source 11 .
  • the LED light source 11 can be arranged inside the body, or outside the body. Since the volume of the light-emitting end 11-1 of the LED light source 11 can be very small, usually the size of the light-emitting end 11-1 is controlled below 2 mm, such as an LED lamp with a package size between 0.2 mm and 0.5 mm. Therefore, the The above-mentioned LED light source 11 can not only be installed outside the body, and conduct light transmission into the human body through the optical tracer carrier 2, but also can be directly installed in the human body, coated with the optical tracer carrier 2, and directly arranged in the place where tracer is required. parts.
  • the optical trace carrier 2 is a light guiding fiber 22 .
  • the light-guiding optical fiber 22 has a good light-guiding effect, and guides the light to different positions as required, and can be switched on or off as required, which is very convenient for clinical use.
  • the light guiding fiber 22 has a non-smooth surface 22 - 1 .
  • the non-smooth surface 22-1 is a non-smooth surface 22-11 capable of forming reflection and/or scattering.
  • the overall luminescence of the non-smooth surface 22-1 can be realized to achieve the effect of overall tracking.
  • the light-guiding optical fiber 22 is intermittently provided with a light outlet 22-2.
  • Each of the light outlets 22-2 provided intermittently has a light transmission surface 22-21 and a reflection surface 22-22, the light is transmitted through the transmission surface 22-21, and when it reaches the reflection surface 22-22, The light is reflected and emitted from the light outlet 22-2 to form a tracer point, and a plurality of the light outlets 22-2 can form a chain tracer strip.
  • the light guiding fiber 22 can be fixed on the anti-displacement mechanism 910-1 through the protective sleeve 5, refer to the figure.
  • the light-guiding optical fiber 22 can also be woven into a net shape, and the light outlets 22-2 are scattered in different positions.
  • the light-guiding optical fiber 22 is braided into a net shape, and the length of each of the light-guiding optical fibers 22 can be set to be different, and the light outlets 22-2 of the light-guiding optical fiber 22 are also different thereupon, scattered and distributed, which can be To realize the overall tracking in the three-dimensional space, since the light outlet 22-1 does not need to be arranged in the middle of each light-guiding optical fiber 22, the light transmission effect is better, and the visual effect of a single tracking point is very bright. It is also possible to weave the light-guiding optical fiber 22 that is provided with the light outlet 22-2 on the side and can be illuminated as a whole into a net shape, so as to realize full-area tracking of the entire anti-displacement mechanism 910-1.
  • the surface of the light guiding fiber 22 may be provided with a coating 3 .
  • the coating 3 can be designed with different properties as required, such as anticoagulation coating, hydrophilic coating or hydrophobic coating.
  • the developing mechanism 4 can also be arranged on the optical tracer carrier 2, and the developing mechanism 4 can be used under X-ray and/or MRI , and/or develop under B-ultrasound.
  • the developing mechanism 4 may be a developing line 41, and/or a developing ring 42, and/or a developing block 43, and the like.
  • the applicant here only exemplifies the above-mentioned several developing methods. In practical applications, those skilled in the art can design different developing methods according to needs. The applicant does not give examples here, but they do not deviate from the scope of the application protected range.
  • the development mechanism 4 can perform development prompts in X-ray, magnetic navigation, or B-ultrasound scenarios, and the development mechanism 4 facilitates the optical tracking carrier 2 to be placed into the tumor tissue under the condition of visualization or navigation Inside, refer to Fig.**.
  • the optical trace carrier 2 is made of flexible medical material, and is arranged on the outer surface of the anti-displacement mechanism 910-1.
  • the proximal end of the light guiding fiber 22 is connected to the light guiding connector 26, the far end of the light guiding fiber 22 is connected and fixed on the anti-displacement mechanism 910-1, the light guiding fiber The light outlet 22-2 of 22 is set on the anti-displacement mechanism 910-1.
  • the light guide fiber 22 is made of flexible medical material, connected and fixed on the anti-displacement mechanism 910-1, when the anti-displacement mechanism 910-1 is deformed , the light guiding fiber 22 is deformed along with the anti-displacement mechanism 910-1.
  • the light guiding fiber 22 can be lighted as a whole, winding the light guiding fiber 22 on the anti-displacement mechanism 910-1, especially on the positioning hook 910-11, can follow the The anti-displacement mechanism 910-1 is deformed together, especially when the anti-displacement mechanism 910-1 is made of shape memory alloy, as the shape of the anti-displacement mechanism 910-1 changes, the guide The shape of the optical fiber 22 also changes accordingly to ensure the tracking effect of the anti-displacement mechanism 910-1.
  • the LED light source 11 When the LED light source 11 adopts a miniature design, the LED light source 11 includes a light-emitting terminal 11-1 and a circuit system 11-2. The light-emitting end 11-1 can be set inside the body.
  • the optical trace carrier 2 is made of a transparent material, and the light-emitting end 11-1 of the LED light source 11 can be packaged on the optical trace carrier 2, and is set together with the optical trace carrier 2 On the anti-displacement mechanism 910-1, trace the anti-displacement mechanism 910-1.
  • the light emitted from the light-emitting end 11-1 is displayed after being transmitted through the light-guiding material of the optical tracer carrier 2, for clinically identifying the position of a solid tumor.
  • the LED light source 11 includes a light-emitting terminal 11-1, a circuit system 11-2, a driving board 11-3 and a power supply 11-4; the light-emitting terminal 11-1 is connected to the drive board 11-3 and the power supply 11-4 through the circuit system 11-2, and under the control of the drive board 11-3, the power supply 11-4 passes through the circuit
  • the system 11-2 supplies power to the light-emitting end 11-1, and the light-emitting end 11-1 emits light; the driving board 11-3 and the power supply 11-4 are arranged outside the body, and the light-emitting end 11-1 In vivo, the anti-displacement mechanism 910-1 is tracked.
  • the circuit system 11-2 is a flexible circuit board 11-21, and the light emitting ends 11-1 of the LED light source 11 are dispersedly arranged on the flexible circuit board 11-21 and packaged in the optical tracer carrier 2, It constitutes an LED light strip, or an LED light net, or an LED light ball, and is arranged on the anti-displacement mechanism 910-1 to track the anti-displacement mechanism 910-1.
  • the LED light source 11 can be packaged with a single light-emitting terminal 11-1 for fixed-point tracing, or the circuit system 11-2 can be used with a flexible circuit board 11-21, and the light-emitting terminals 11-1 can be dispersed be arranged at any position of the flexible circuit board 11-21 to form a light strip, and the light strip is wound on the anti-displacement mechanism 910-1, or a plurality of the LED light sources 11 and the optical display
  • the tracking carrier 2 is packaged together into a shape such as a mesh or a ball, and the overall tracking of the anti-displacement mechanism 910-1 is carried out.
  • the light-emitting end 11-1 of the LED light source 11 can also be directly arranged on the anti-displacement mechanism 910-1, and the optical trace carrier 2 made of transparent material is coated on the outside, and the light-emitting end 11-1 The emitted light traces the anti-displacement mechanism 910-1.
  • the light-emitting end 11-1 can be directly arranged on the anti-displacement mechanism 910-1, and then the optical tracer carrier 2 made of transparent material is coated on the outside, so that the light-emitting end 11-1 can be completely It fits the outer contour of the anti-displacement mechanism 910-1 accurately, and traces any shape of the anti-displacement mechanism 910-1.
  • the light-emitting end 11-1 is arranged symmetrically, and the outside covers the optical tracer carrier 2, and the internal support of the light-emitting end 11-1 and the circuit system 11-2 and the light-emitting end 11-1 Its own volume can constitute the anti-displacement mechanism 910-1, and the medical optical tracer system 500 can have both the tracing function and the positioning function of the anti-displacement mechanism 910-1, refer to Fig. 7 to Fig. 7-4.
  • the circuit system 11-2 is a flexible circuit board 11-21
  • the optical trace carrier 2 is made of soft transparent material
  • the light-emitting terminal 11-1, the flexible circuit board 11-21 and the developing mechanism 4 They are arranged together in the optical trace carrier 2 and on the anti-displacement mechanism 910-1.
  • the anti-displacement mechanism 910-1 is deformed, the light-emitting end 11-1, the The flexible circuit board 11 - 21 , the developing mechanism 4 and the optical trace carrier 2 are deformed together with the anti-displacement mechanism 910 - 1 .
  • the anti-displacement mechanism 910-1 is made of shape memory alloy, as the shape of the anti-displacement mechanism 910-1 changes, the shape of the flexible circuit board 11-21 also changes accordingly. , to ensure the tracking effect on the anti-displacement mechanism 910-1.
  • the optical trace carrier 2 is a light-storing self-luminous trace carrier 21 .
  • Self-luminous materials refer to materials that can absorb energy in a certain way and convert it into non-equilibrium light radiation. The process of converting the energy absorbed inside the material into non-equilibrium light radiation is the luminescence process.
  • light-storing self-luminescent materials can continue to emit light for more than 12 hours in a dark environment after a few minutes or tens of minutes under the action of external light, which can meet the tracing needs of most operations.
  • the light-storing self-illuminating tracer carrier 21 can directly absorb the energy of the light in the operating room, so that various external lights can form the light source 1, and there is no need to directly connect the light source 1, and the use process is very simple.
  • the light-storage self-luminous tracer carrier 21 includes a light-storage self-illuminator 21-1 and a protection carrier 21-2.
  • the protective carrier 21-2 is made of a transparent light-guiding material, and the light-storing self-luminous body 21-1 is closed and arranged in the protective carrier 21-2.
  • the light-storing self-luminous body 21-1 can absorb external energy and convert it into light.
  • the protective carrier 21-2 is made of transparent medical materials, which can be directly in contact with tissues.
  • the light energy converted from the light-storing self-illuminating body 21-1 effectively passes through for effective tracing, and at the same time ensures clinical Biosafety used.
  • the light-storing self-illuminating body 21-1 can be arranged in different positions and designed in different shapes, and can perform fixed-point tracking or overall tracking as required.
  • the anti-displacement mechanism 910-1 is set in the delivery sheath 910-21, and Under the X-ray state, the delivery sheath 910-21 is inserted into the position of the solid tumor, and then the anti-displacement mechanism 910-1 is pushed out by the pushing mechanism 910-22, and fixed on the lung tumor (especially the lung nodule). ), or liver tumors and other solid tumors, and then remove the delivery sheath 910-21, stay and fix the anti-displacement mechanism 910-1 on the solid tumor, and then connect the light-guiding optical fiber 22 to the On the light source 1, refer to Figure 13-1.
  • the light source 1 is turned on, and the optical tracer carrier 2 traces the anti-displacement mechanism 910-1, so that under the guidance of light, the naked eye can see Visually observe the location of lung tumors (especially lung nodules), or solid tumors such as liver tumors.
  • the anti-displacement mechanism 910-1 can be delivered to the uterine fibroids and fixed on the uterine fibroids.
  • the light source 1 and the optical tracer 2 trace the anti-displacement mechanism 910-1, so that the position of the uterine fibroids can be visually observed with the naked eye under the guidance of the light.
  • the solid tumor tracking device of this embodiment is designed with the medical optical tracking system 500.
  • the solid tumor tracking device of the present invention can track solid tumors through visible light after entering the human body.
  • the light source 1 and the optical tracer carrier trace the anti-displacement mechanism 910-1, so that the position of the solid tumor can be visually observed with the naked eye under the guidance of the light, and the clinical operation is safer and more convenient.

Abstract

A solid tumor tracing device (910), including an anti-displacement mechanism (910-1), a delivery mechanism (910-2), a development mechanism (4) and a medical optical tracing system (500), wherein the medical optical tracing system (500) performs optical tracing on the anti-displacement mechanism (910-1). The medical optical tracing system (500) includes a light source (1) and an optical tracing carrier (2). After light emitted by the light source (1) is conducted by means of the optical tracing carrier (2), optical tracing is performed on the optical tracing carrier (2). The light source (1) may also be a miniature LED light source (11), and a light-emitting end (11-1) of the LED light source (11) and the optical tracing carrier (2) are directly arranged as a whole, and are then placed into a human body for optical tracing. The medical optical tracing system (500) is designed; therefore, after entering a human body, the solid tumor tracing device (910) can trace a solid tumor by means of visible light; during surgery, the light source (1) is switched on, and the optical tracing carrier (2) traces the anti-displacement mechanism (910-1), such that the position of the solid tumor can be visually observed by the naked eye under the guidance of light; therefore, clinical surgery is safer and more convenient.

Description

实体瘤示踪装置Solid Tumor Tracer 技术领域technical field
本发明涉及一种医用示踪系统,特别是一种实体瘤示踪装置。The invention relates to a medical tracing system, in particular to a solid tumor tracing device.
背景技术Background technique
随着医学影像设备分辨率的大幅提高,一些肿瘤组织在很小体积时就能被发现,如肺结节、子宫肌瘤、食道肿瘤、肝肿瘤等。由于这些肿瘤组织体积小,如肺结节,在腔镜下切除时,很难准确鉴别,因此,需要对需要切除的肿瘤组织进行标识,方便在腔镜下进行手术切除。With the sharp increase in the resolution of medical imaging equipment, some tumor tissues can be found in very small volumes, such as lung nodules, uterine fibroids, esophageal tumors, and liver tumors. Due to the small size of these tumor tissues, such as pulmonary nodules, it is difficult to accurately identify them during laparoscopic resection. Therefore, it is necessary to mark the tumor tissues that need to be removed to facilitate surgical resection under laparoscope.
目前的小体积肿瘤组织的标定通常是在X光环境下,置入定位钩等标识机构,然后将定位钩等标识机构留存在肿瘤组织处,在手术过程中,通过识别标识机构的位置来进行手术。The current calibration of small-volume tumor tissue is usually carried out by placing marking mechanisms such as positioning hooks in the X-ray environment, and then leaving the positioning hooks and other marking mechanisms at the tumor tissue. During the operation, the position of the marking mechanism is identified. Operation.
因标识机构通常体积很小,且在X光等环境下才容易显影,因此,在腔镜下,手术过程中时,由于血液等的干扰作用,标识机构经常很难识别出来,从而造成手术过程很难准确判断肿瘤的位置。Because the marking mechanism is usually small in size and is easy to develop in X-ray and other environments, it is often difficult to identify the marking mechanism under the endoscope and during the operation due to the interference of blood, etc., resulting in It is difficult to accurately determine the location of the tumor.
本发明公开了一种基于可见光技术的肿瘤组织,尤其是实体瘤的标定技术和装置。The invention discloses a tumor tissue based on visible light technology, especially a calibration technology and device for solid tumors.
发明内容Contents of the invention
本发明的目的在于解决现有临床手术中小体积肿瘤组织或实体瘤组织无法准确辨别所在位置的问题,通过采用光学示踪方式的设置,在临床手术中,通过不同颜色光源的设置,准确辨别临床手术中需要切除的肿瘤组织,方便在腔镜下进行肿瘤组织的手术切除。The purpose of the present invention is to solve the problem that the location of small-volume tumor tissue or solid tumor tissue cannot be accurately identified in the existing clinical operation. By adopting the setting of optical tracing method, in clinical operation, through the setting of light sources of different colors, it can accurately identify the location of the clinical tumor tissue or solid tumor tissue. The tumor tissue that needs to be removed during the operation is convenient for surgical resection of the tumor tissue under the laparoscope.
本发明之实体瘤示踪装置,其特征在于:所述实体瘤示踪装置910含医用光学示踪系统500;所述医用光学示踪系统500置入实体瘤中,并通过可见光示踪技术对实体瘤进行位置标识。The solid tumor tracking device of the present invention is characterized in that: the solid tumor tracking device 910 includes a medical optical tracking system 500; Solid tumors were identified by location.
所述医用光学示踪系统500在所述光学示踪载体2的作用下,能发出可见光,在临床 手术中,通过可见光的提示,就可以快速、有效地进行实体瘤的识别,并进行手术切除。The medical optical tracer system 500 can emit visible light under the action of the optical tracer carrier 2. In clinical operations, solid tumors can be quickly and effectively identified and resected by the prompt of visible light. .
所述实体瘤示踪装置910含显影机构4。所述显影机构4在X光、磁导航、或B超等场景下能进行显影提示,便于所述实体瘤示踪装置910的置入。The solid tumor tracking device 910 includes a developing mechanism 4 . The development mechanism 4 can provide development prompts in X-ray, magnetic navigation, or B-ultrasound scenarios, which facilitates the placement of the solid tumor tracking device 910 .
所述实体瘤示踪装置910含防移位机构910-1。所述防移位机构910-1可以固定在需要被标定的实体瘤上,以防止所述实体瘤示踪装置910随着人体运动,如肺部呼吸运动、肠道蠕动、胃部蠕动等而移位。The solid tumor tracking device 910 includes an anti-displacement mechanism 910-1. The anti-displacement mechanism 910-1 can be fixed on the solid tumor that needs to be calibrated, so as to prevent the solid tumor tracking device 910 from moving with the movement of the human body, such as lung breathing movement, intestinal peristalsis, gastric peristalsis, etc. shift.
所述实体瘤示踪装置910含递送机构910-2。所述递送机构910-2能将所述防移位机构910-1递送至需要标识的实体瘤处。The solid tumor tracking device 910 includes a delivery mechanism 910-2. The delivery mechanism 910-2 can deliver the anti-displacement mechanism 910-1 to a solid tumor that needs to be marked.
临床应用中,所述递送机构910-2在X光、或MRI状态下,将所述防移位机构910-1递送至实体瘤所在的位置,并固定在实体瘤上,所述光学示踪载体2设置在所述防移位机构910-1上,对所述防移位机构910-1进行定位,手术中,就能够在光线的指引下,肉眼直观地观察到实体瘤所在的位置。In clinical applications, the delivery mechanism 910-2 delivers the anti-displacement mechanism 910-1 to the position of the solid tumor under X-ray or MRI conditions, and fixes it on the solid tumor. The carrier 2 is arranged on the anti-displacement mechanism 910-1. By positioning the anti-displacement mechanism 910-1, the position of the solid tumor can be visually observed with the naked eye under the guidance of the light during the operation.
所述防移位机构910-1工作状态时呈钩状结构、和/或喇叭形结构、和/或哑铃型结构、和/或螺旋弹簧型结构、和/或钉状结构。申请人在此只举例说明了上述几种结构的所述防移位机构910-1的方式,实际应用中,本领域的技术人员可以根据需要设计出不同结构的所述防移位机构910-1,申请人在此不一一举例说明,但都不脱离本申请的保护范围。The anti-displacement mechanism 910-1 has a hook-shaped structure, and/or a trumpet-shaped structure, and/or a dumbbell-shaped structure, and/or a coil spring-shaped structure, and/or a nail-shaped structure in a working state. The applicant here only exemplifies the manners of the anti-displacement mechanism 910-1 with the above-mentioned several structures. In practical applications, those skilled in the art can design the anti-displacement mechanism 910-1 with different structures as required 1. The applicant does not give examples one by one here, but they all do not depart from the protection scope of the present application.
所述防移位机构910-1呈钩状结构,至少含1个定位钩910-11。The anti-displacement mechanism 910-1 has a hook-like structure and includes at least one positioning hook 910-11.
所述防移位机构910-1含2个定位钩910-11。通常,所述防移位机构910-1含2个或3个所述定位钩910-11,以更好地防止所述防移位机构910-1随着人体的运动,如肺部的呼吸运动、肠道的蠕动等而发生移位。The anti-displacement mechanism 910-1 includes two positioning hooks 910-11. Usually, the anti-displacement mechanism 910-1 includes 2 or 3 positioning hooks 910-11 to better prevent the anti-displacement mechanism 910-1 from moving with the human body, such as the breathing of the lungs. Displacement occurs due to movement, intestinal peristalsis, etc.
所述防移位机构910-1由形状记忆合金制造,在体外时呈线性结构,进入人体后在体温的作用下恢复成设定的钩状结构、和/或喇叭形结构、和/或哑铃型结构、和/或螺旋弹簧型结构、和/或钉状结构。The anti-displacement mechanism 910-1 is made of shape memory alloy, and has a linear structure outside the body, and returns to the set hook structure, and/or horn-shaped structure, and/or dumbbell after entering the human body under the action of body temperature Type structure, and/or helical spring type structure, and/or nail-like structure.
所述防移位机构910-1由显影材料制成,构成所述显影机构4,在X光下、和/或MRI下、和/或B超下进行显影。临床使用时,在X光下、和/或MRI下、和/或B超下,所述防移位机构910-1被置入需要标定的肿瘤组织内。The anti-displacement mechanism 910-1 is made of developing material, which constitutes the developing mechanism 4, and develops under X-ray and/or MRI and/or B-ultrasound. In clinical use, under X-ray, and/or MRI, and/or B-ultrasound, the anti-displacement mechanism 910-1 is placed in the tumor tissue that needs to be marked.
所述递送机构910-2含推送机构910-21和递送鞘管910-22。The delivery mechanism 910-2 includes a push mechanism 910-21 and a delivery sheath 910-22.
所述防移位机构910-1被设置在所述递送鞘管910-22内,所述推送机构910-21能将所述防移位机构910-1从所述递送鞘管910-22内推出置入实体瘤内。The anti-displacement mechanism 910-1 is set in the delivery sheath 910-22, and the pushing mechanism 910-21 can push the anti-displacement mechanism 910-1 out of the delivery sheath 910-22. Launched into solid tumors.
所述推送机构910-22可以和所述防移位机构910-1固定连接,将所述防移位机构910-1从所述递送鞘910-21中推出后一起停留在体内;所述推送机构910-22也可以和所述防移位机构910-1可拆卸连接,将所述防移位机构910-1从所述递送鞘910-21中推出后,和所 述防移位机构910-1解除连接,只将所述防移位机构910-1留置在实体瘤处。The pushing mechanism 910-22 can be fixedly connected with the anti-displacement mechanism 910-1, and stay in the body together after the anti-displacement mechanism 910-1 is pushed out from the delivery sheath 910-21; The mechanism 910-22 can also be detachably connected with the anti-displacement mechanism 910-1, after the anti-displacement mechanism 910-1 is pushed out from the delivery sheath 910-21, and the anti-displacement mechanism 910 - 1 Disconnect, and only place the anti-displacement mechanism 910-1 on the solid tumor.
所述医用光学示踪系统500含光源1和光学示踪载体2;The medical optical tracer system 500 includes a light source 1 and an optical tracer carrier 2;
A、所述光学示踪载体2含导光材料;A. The optical trace carrier 2 contains a light-guiding material;
B、所述光源1发出的光经所述光学示踪载体2进行传导,并对所述光学示踪载体2进行光学示踪。B. The light emitted by the light source 1 is transmitted through the optical trace carrier 2, and the optical trace carrier 2 is optically traced.
所述光学示踪载体2能对所述移位机构910-1进行光学示踪。The optical tracking carrier 2 can perform optical tracking on the displacement mechanism 910-1.
所述光源1是LED光源11、和/或医用冷光源12、和/或自然光。所述光源1可以是各种能发出光线的光源,所述光源1发出的光线可以经所述光学示踪载体1传导后进行示踪。所述LED光源11与普通照明光源相比,具有体积小、发光效率高、光源指向性强等特点,尤其是在安全性方面,LED光源有普通光源无法比拟的优势。首先LED光源是低压直流供电,供电电压只需6到24V;其次LED光源中不添加汞,不会对人体造成中毒等伤害;此外更重要的是LED光源是冷光源,在工作过程中不会严重发热,可以安全触摸,不会对人体造成意外的高温烫伤。所述医用冷光源12是现有手术过程中的常用光源,而且可以将所述光源1后置,手术室中容易获得,不需要额外的设备。The light source 1 is an LED light source 11, and/or a medical cold light source 12, and/or natural light. The light source 1 can be various light sources capable of emitting light, and the light emitted by the light source 1 can be traced after being transmitted through the optical trace carrier 1 . Compared with ordinary lighting sources, the LED light source 11 has the characteristics of small size, high luminous efficiency, and strong light source directivity. Especially in terms of safety, LED light sources have incomparable advantages over ordinary light sources. First of all, the LED light source is a low-voltage DC power supply, and the power supply voltage only needs to be 6 to 24V; secondly, no mercury is added to the LED light source, which will not cause poisoning or other harm to the human body; more importantly, the LED light source is a cold light source, which will not cause harm to the human body during work. Severe heat, safe to touch, will not cause unexpected high temperature burns to the human body. The medical cold light source 12 is a commonly used light source in the existing operation process, and the light source 1 can be placed behind, which is easy to obtain in the operating room and does not require additional equipment.
所述光源1发出的光线的颜色可以根据背景颜色或穿透要求进行设置。通过光线的设置,在临床手术中,医生可以直接通过肉眼透过组织看到所述光学示踪载体2所在的位置,进而准确辨别临床手术中,需要重点保护的血管、组织或器官,有效避免手术过程中的意外伤害。所述光源1发出的光线可以根据体腔内的背景颜色或需要穿透的组织进行差异化设置,当需要穿透组织时,红色和黄色为佳,紫色和白色次之。The color of light emitted by the light source 1 can be set according to background color or penetration requirements. Through the setting of the light, in the clinical operation, the doctor can directly see the position of the optical tracer 2 through the tissue with the naked eye, and then accurately identify the blood vessels, tissues or organs that need to be protected during the clinical operation, effectively avoiding Accidental injury during surgery. The light emitted by the light source 1 can be differentiated according to the background color in the body cavity or the tissue to be penetrated. When the tissue needs to be penetrated, red and yellow are the best, followed by purple and white.
所述光源1是闪烁型发光。所述光源1还可以根据需要设置成间断点亮、闪烁等形式。The light source 1 is a flashing type of light emitting. The light source 1 can also be set in the form of intermittent lighting, flashing, etc. as required.
所述光源1发出的光线的强度可以进行设置。所述光源1发出的光线的强度也可以根据需要进行调整,以适应不同的临床环境。所述光源1发出的光线的照度可达30万lux,较佳范围在5千lux至15万lux。The intensity of light emitted by the light source 1 can be set. The intensity of the light emitted by the light source 1 can also be adjusted as required to adapt to different clinical environments. The illuminance of the light emitted by the light source 1 can reach 300,000 lux, preferably ranging from 5,000 lux to 150,000 lux.
所述光源1含控制系统13,所述控制系统13含波长调节机构13-1和光强调节机构13-2,所述波长调节机构13-1能通过波长的调节来调节发出的光线的颜色,所述光强调节机构13-2,能调节发出的光线的照度。The light source 1 includes a control system 13, the control system 13 includes a wavelength adjustment mechanism 13-1 and a light intensity adjustment mechanism 13-2, and the wavelength adjustment mechanism 13-1 can adjust the color of the emitted light by adjusting the wavelength , the light intensity adjusting mechanism 13-2 can adjust the illuminance of the emitted light.
所述LED光源11设置在体内、和/或体外。由于所述LED光源11的发光端11-1的体积可以非常小,因此,所述LED光源11不但能设置在体外,通过所述光学示踪载体2向人体内进行光线传导,而且可以直接设置在人体内,外部包覆所述光学示踪载体2,直接设置在需要示踪的部位。The LED light source 11 is arranged inside the body and/or outside the body. Since the volume of the light-emitting end 11-1 of the LED light source 11 can be very small, the LED light source 11 can not only be installed outside the body, and transmit light to the human body through the optical tracer carrier 2, but also can be directly installed In the human body, the optical tracking carrier 2 is coated on the outside and placed directly on the part that needs to be tracked.
所述光学示踪载体2是蓄光自发光示踪载体21。自发光材料是指能够以某种方式吸收能量,将其转化成非平衡光辐射的物质材料,材料内部吸收的能量转化为非平衡光辐射的 过程就是发光过程。尤其是蓄光自发光材料在外界光照作用下几分钟或几十分钟之后,在黑暗的环境下可持续发光12小时以上,可以满足大多数手术时长的示踪需求。所述蓄光自发光示踪载体21可以直接吸收手术室中灯光的能量,使得各种外部光照都能构成所述光源1,不需要直接连接所述光源1,使用过程非常简单。The optical tracer 2 is a light-storage self-luminous tracer 21 . Self-luminous materials refer to materials that can absorb energy in a certain way and convert it into non-equilibrium light radiation. The process of converting the energy absorbed inside the material into non-equilibrium light radiation is the luminescence process. In particular, light-storing self-luminescent materials can continue to emit light for more than 12 hours in a dark environment after a few minutes or tens of minutes under the action of external light, which can meet the tracing needs of most operations. The light-storing self-illuminating tracer carrier 21 can directly absorb the energy of the light in the operating room, so that various external lights can form the light source 1, and there is no need to directly connect the light source 1, and the use process is very simple.
所述蓄光自发光示踪载体21含蓄光自发光体21-1和保护载体21-2。The light-storage self-luminous tracer carrier 21 includes a light-storage self-illuminator 21-1 and a protection carrier 21-2.
所述保护载体21-2由透明导光材料制成,所述蓄光自发光体21-1封闭设置在所述保护载体21-2内。The protective carrier 21-2 is made of a transparent light-guiding material, and the light-storing self-luminous body 21-1 is closed and arranged in the protective carrier 21-2.
所述蓄光自发光体21-1能吸收外部能量,并进行转化发光。所述保护载体21-2采用透明医用材料制成,可以直接和组织进行接触,所述蓄光自发光体21-1能量转化发出的光能有效透过进行有效示踪的同时,还保证了临床使用的生物安全性。所述蓄光自发光体21-1能设置在不同的位置,并设计成不同形状,根据需要进行定点示踪或进行整体示踪。The light-storing self-luminous body 21-1 can absorb external energy and convert it into light. The protective carrier 21-2 is made of transparent medical materials, which can be directly in contact with tissues. The light energy converted from the light-storing self-illuminating body 21-1 effectively passes through for effective tracing, and at the same time ensures clinical Biosafety used. The light-storing self-illuminating body 21-1 can be arranged in different positions and designed in different shapes, and can perform fixed-point tracking or overall tracking as required.
所述光学示踪载体2是导光光纤22。所述导光光纤22具有良好的导光效果,并根据需要将光线传导至各个不同的位置,而且可以根据需要接通或切断,临床使用非常方便。The optical trace carrier 2 is a light guiding fiber 22 . The light-guiding optical fiber 22 has a good light-guiding effect, and guides the light to different positions as required, and can be switched on or off as required, which is very convenient for clinical use.
所述导光光纤22具有非光滑的表面22-1。The light guiding fiber 22 has a non-smooth surface 22-1.
所述非光滑的表面22-1是能形成反射、和/或散射的非光滑表面22-11。所述非光滑的表面22-1经过光线的反射、和/或散射,可以实现所述非光滑的表面22-1的整体发光,达到整体示踪的效果。The non-smooth surface 22-1 is a non-smooth surface 22-11 capable of forming reflection and/or scattering. The non-smooth surface 22-1 can realize the overall light emission of the non-smooth surface 22-1 through the reflection and/or scattering of light, so as to achieve the effect of overall tracking.
所述导光光纤22上间断式设置有出光口22-2。间断式设置的每个所述出光口22-2具有光线的传导面22-21和反射面22-22,光线经所述传导面22-21进行传导,至所述反射面22-22时,光线发生反射,从所述出光口22-2射出,形成一个示踪点,多个所述出光口22-2可形成链状示踪带。The light-guiding optical fiber 22 is intermittently provided with a light outlet 22-2. Each of the light outlets 22-2 provided intermittently has a light transmission surface 22-21 and a reflection surface 22-22, the light is transmitted through the transmission surface 22-21, and when it reaches the reflection surface 22-22, The light is reflected and emitted from the light outlet 22-2 to form a tracer point, and a plurality of the light outlets 22-2 can form a chain tracer strip.
所述导光光纤22编织成网状,不同位置散落状分布有出光口22-2。所述导光光纤22编织成网状,可以通过将每一根所述导光光纤22的长度设置成不同,所述导光光纤22的出光口22-2也随之不同,散落分布,可实现立体空间的整体示踪,由于每一根所述导光光纤22中间不需要设置所述出光口22-1,因此光线传导效果更好,单个示踪点的视觉效果非常明亮。也可以将侧面设置有所述出光口22-2,能整体点亮的所述导光光纤22编织成网状,实现整个所述防移位机构910-1的全面积示踪。The light-guiding optical fiber 22 is braided into a net shape, and light outlets 22-2 are scattered in different positions. The light-guiding optical fiber 22 is braided into a net shape, and the length of each of the light-guiding optical fibers 22 can be set to be different, and the light outlets 22-2 of the light-guiding optical fiber 22 are also different thereupon, scattered and distributed, which can be To realize the overall tracking in the three-dimensional space, since the light outlet 22-1 does not need to be arranged in the middle of each light-guiding optical fiber 22, the light transmission effect is better, and the visual effect of a single tracking point is very bright. It is also possible to weave the light-guiding optical fiber 22 that is provided with the light outlet 22-2 on the side and can be illuminated as a whole into a net shape, so as to realize full-area tracking of the entire anti-displacement mechanism 910-1.
所述导光光纤22表面含涂层3。所述涂层3可以根据需要进行设计不同性质的涂层,如抗凝涂层、亲水涂层或疏水涂层。The surface of the light guiding fiber 22 contains a coating 3 . The coating 3 can be designed with different properties as required, such as anticoagulation coating, hydrophilic coating or hydrophobic coating.
所述光学示踪载体2上设有显影机构4,所述显影机构4在X光下、和/或MRI下、和/或B超下进行显影。所述显影机构4可以是显影线、和/或显影环、和/或显影块等。申请人在此只举例说明了上述几种显影方式,实际应用中,本领域的技术人员可以根据需要设 计出不同的显影方式,申请人在此不一一举例说明,但都不脱离本申请的保护范围。所述显影机构4在X光、磁导航、或B超等场景下能进行显影提示,所述显影机构4便于所述光学示踪载体2能在可视或导航的情况下被置入肿瘤组织内。The optical trace carrier 2 is provided with a developing mechanism 4, and the developing mechanism 4 performs developing under X-ray, and/or MRI, and/or B-ultrasound. The developing mechanism 4 may be a developing line, and/or a developing ring, and/or a developing block and the like. The applicant here only exemplifies the above-mentioned several developing methods. In practical applications, those skilled in the art can design different developing methods according to needs. The applicant does not give examples here, but they do not deviate from the scope of the application protected range. The development mechanism 4 can perform development prompts in X-ray, magnetic navigation, or B-ultrasound scenarios, and the development mechanism 4 facilitates the optical tracking carrier 2 to be placed into the tumor tissue under the condition of visualization or navigation Inside.
所述光学示踪载体2由柔顺的医用材料制成,设置在所述防移位机构910-1的外表面。The optical trace carrier 2 is made of flexible medical material, and is arranged on the outer surface of the anti-displacement mechanism 910-1.
所述光学示踪载体2是导光光纤22,所述导光光纤22的近端与导光接头26连接,所述导光光纤22的远端连接、固定在所述防移位机构910-1上,所述导光光纤22的出光口22-2设置在所述防移位机构910-1上,对所述防移位机构910-1进行示踪。The optical tracer carrier 2 is a light guide fiber 22, the proximal end of the light guide fiber 22 is connected to the light guide joint 26, and the far end of the light guide fiber 22 is connected and fixed on the anti-displacement mechanism 910- 1, the light outlet 22-2 of the light guide fiber 22 is set on the anti-displacement mechanism 910-1, and traces the anti-displacement mechanism 910-1.
所述导光光纤22具有非光滑的表面22-1,所述导光光纤22的侧面设有出光口22-2,所述导光光纤22对所述防移位机构910-1进行整体示踪。The light guiding fiber 22 has a non-smooth surface 22-1, and the side of the light guiding fiber 22 is provided with a light outlet 22-2, and the light guiding fiber 22 is an overall display of the anti-displacement mechanism 910-1. trace.
所述导光光纤22由柔顺的医用材料制成,连接固定在所述防移位机构910-1上,当所述防移位机构910-1发生变形时,所述导光光纤22随着所述防移位机构910-1发生变形。由于所述导光光纤22能整体点亮,因此,将所述导光光纤22缠绕在所述防移位机构910-1上,尤其是所述定位钩910-11上,就可以随着所述防移位机构910-1一起发生变形,尤其是当所述防移位机构910-1采用形状记忆合金制造时,随着所述防移位机构910-1的形状发生变化,所述导光光纤22的形状也随之发生变化,保证对所述防移位机构910-1的示踪效果。The light guiding fiber 22 is made of flexible medical materials, and is connected and fixed on the anti-displacement mechanism 910-1. When the anti-displacement mechanism 910-1 is deformed, the light guiding fiber 22 follows the The anti-displacement mechanism 910-1 is deformed. Since the light guiding fiber 22 can be lighted as a whole, winding the light guiding fiber 22 on the anti-displacement mechanism 910-1, especially on the positioning hook 910-11, can follow the The anti-displacement mechanism 910-1 is deformed together, especially when the anti-displacement mechanism 910-1 is made of shape memory alloy, as the shape of the anti-displacement mechanism 910-1 changes, the guide The shape of the optical fiber 22 also changes accordingly to ensure the tracking effect of the anti-displacement mechanism 910-1.
所述医用光学示踪系统500的光源1是LED光源11,所述光学示踪载体2由透明材料制成,所述LED光源11的发光端11-1设置在所述光学示踪载体2上,与所述光学示踪载体2一起设置在所述防移位机构910-1上或所述防移位机构910-1上,对所述防移位机构910-1进行示踪。The light source 1 of the medical optical tracer system 500 is an LED light source 11, the optical tracer carrier 2 is made of a transparent material, and the light-emitting end 11-1 of the LED light source 11 is set on the optical tracer carrier 2 , set on or on the anti-displacement mechanism 910-1 together with the optical trace carrier 2, and trace the anti-displacement mechanism 910-1.
当所述光源1采用所述LED光源11时,所述LED光源11的发光端11-1可以和所述光学示踪载体2封装成一个整体,共同设置在所述防移位机构910-1需要示踪的位置,所述发光端11-1发出的光线经所述光学示踪载体2的导光材料传导后显示,供临床辨别实体瘤的位置。When the light source 1 adopts the LED light source 11, the light-emitting end 11-1 of the LED light source 11 can be packaged with the optical trace carrier 2 as a whole, and they are jointly arranged on the anti-displacement mechanism 910-1. For the location that needs to be traced, the light emitted by the light-emitting end 11-1 is displayed after being transmitted through the light-guiding material of the optical tracer carrier 2, for clinically identifying the location of the solid tumor.
所述LED光源11含发光端11-1、电路系统11-2、驱动板11-3和电源11-4;所述发光端11-1通过所述电路系统11-2和所述驱动板11-3及所述电源11-4连接,在所述驱动板11-3的控制下,所述电源11-4通过所述电路系统11-2对所述发光端11-1供电,所述发光端11-1发出光线;所述驱动板11-3及所述电源11-4设置在体外,所述发光端11-1设置在体内,对所述防移位机构910-1进行示踪。The LED light source 11 includes a light-emitting terminal 11-1, a circuit system 11-2, a drive board 11-3, and a power supply 11-4; the light-emitting terminal 11-1 passes through the circuit system 11-2 and the drive board 11 -3 and the power supply 11-4 are connected, and under the control of the driving board 11-3, the power supply 11-4 supplies power to the light emitting terminal 11-1 through the circuit system 11-2, and the light emitting The end 11-1 emits light; the driving board 11-3 and the power supply 11-4 are arranged outside the body, and the light emitting end 11-1 is arranged inside the body to trace the anti-displacement mechanism 910-1.
所述电路系统11-2是柔性电路板11-21,所述LED光源11的发光端11-1分散设置在所述柔性电路板11-21上并封装在所述光学示踪载体2内,构成LED灯带、或LED灯网、或LED灯球,设置在所述防移位机构910-1上,对所述防移位机构910-1进行示踪。The circuit system 11-2 is a flexible circuit board 11-21, and the light emitting ends 11-1 of the LED light source 11 are dispersedly arranged on the flexible circuit board 11-21 and packaged in the optical tracer carrier 2, It constitutes an LED light strip, or an LED light net, or an LED light ball, and is arranged on the anti-displacement mechanism 910-1 to track the anti-displacement mechanism 910-1.
所述LED光源11可以是采用单个所述发光端11-1封装后进行定点示踪。也可以是将所述电路系统11-2采用柔性电路板11-21,所述发光端11-1分散地设置在所述柔性电路板11-21的任何位置,从而形成发光带,将光带缠绕在所述防移位机构910-1上,或将多条所述LED光源11与所述光学示踪载体2一起封装成网状、球状等形状,对所述防移位机构910-1进行整体示踪。The LED light source 11 can be packaged with a single light-emitting terminal 11-1 for fixed-point tracking. It is also possible to use a flexible circuit board 11-21 for the circuit system 11-2, and the light-emitting ends 11-1 are dispersedly arranged at any position of the flexible circuit board 11-21, thereby forming a light-emitting strip, and the light-emitting strip Winding on the anti-displacement mechanism 910-1, or packaging multiple LED light sources 11 together with the optical tracer carrier 2 into a net shape, spherical shape, etc., the anti-displacement mechanism 910-1 Carry out overall tracing.
所述LED光源11的发光端11-1设置在所述防移位机构910-1上,外部包覆透明材料制成的所述光学示踪载体2,所述发光端11-1发出的光线对所述防移位机构910-1进行示踪。The light-emitting end 11-1 of the LED light source 11 is arranged on the anti-displacement mechanism 910-1, and the outside is coated with the optical tracer carrier 2 made of transparent material, and the light emitted by the light-emitting end 11-1 The anti-displacement mechanism 910-1 is traced.
所述发光端11-1分散地设置在所述防移位机构910-1上,对所述防移位机构(910-1)进行整体示踪。The light-emitting ends 11-1 are dispersedly arranged on the anti-displacement mechanism 910-1, and trace the entire anti-displacement mechanism (910-1).
所述发光端11-1可以直接设置在所述防移位机构910-1上,然后外部包覆透明材料制成的所述光学示踪载体2,这样所述发光端11-1就可以完整地贴合所述防移位机构910-1的外部轮廓,对所述防移位机构910-1形状任何形状的示踪。The light-emitting end 11-1 can be directly arranged on the anti-displacement mechanism 910-1, and then the optical tracer carrier 2 made of transparent material is coated on the outside, so that the light-emitting end 11-1 can be completely It fits the outer contour of the anti-displacement mechanism 910-1 accurately, and traces any shape of the anti-displacement mechanism 910-1.
此外,所述发光端11-1对称设置,外部包覆所述光学示踪载体2,利用所述发光端11-1和所述电路系统11-2的内部支撑和所述发光端11-1的自身体积,可构成所述防移位机构910-1,所述医用光学示踪系统500可以同时兼具示踪功能和所述防移位机构910-1的定位功能。In addition, the light-emitting end 11-1 is arranged symmetrically, and the outside covers the optical tracer carrier 2, and the internal support of the light-emitting end 11-1 and the circuit system 11-2 and the light-emitting end 11-1 Its own volume can constitute the anti-displacement mechanism 910-1, and the medical optical tracking system 500 can simultaneously have the tracking function and the positioning function of the anti-displacement mechanism 910-1.
所述电路系统11-2是柔性电路板11-21,所述光学示踪载体2由柔软的透明材料制成,所述发光端11-1、所述柔性电路板11-21和显影机构4一起设置在所述光学示踪载体2内,并设置在所述防移位机构910-1上,当所述防移位机构910-1发生变形时,所述发光端11-1、所述柔性电路板11-21、所述显影机构4和所述光学示踪载体2一起随着所述防移位机构910-1发生变形。尤其是当所述防移位机构910-1采用形状记忆合金制造时,随着所述防移位机构910-1的形状发生变化,所述柔性电路板11-21的形状也随之发生变化,保证对所述防移位机构910-1的示踪效果。The circuit system 11-2 is a flexible circuit board 11-21, the optical trace carrier 2 is made of soft transparent material, the light-emitting terminal 11-1, the flexible circuit board 11-21 and the developing mechanism 4 They are arranged together in the optical trace carrier 2 and on the anti-displacement mechanism 910-1. When the anti-displacement mechanism 910-1 is deformed, the light-emitting end 11-1, the The flexible circuit board 11 - 21 , the developing mechanism 4 and the optical trace carrier 2 are deformed together with the anti-displacement mechanism 910 - 1 . Especially when the anti-displacement mechanism 910-1 is made of shape memory alloy, as the shape of the anti-displacement mechanism 910-1 changes, the shape of the flexible circuit board 11-21 also changes accordingly. , to ensure the tracking effect on the anti-displacement mechanism 910-1.
临床使用时,所述防移位机构910-1设置在所述递送鞘910-21内,在X光、或MRI状态下,所述递送鞘910-21插入实体瘤所在的位置,然后用所述推送机构910-22将所述防移位机构910-1推出,固定在实体瘤上,然后撤除所述递送鞘910-21,将所述防移位机构910-1停留、固定在实体瘤上,手术时,接通所述光源1,所述光学示踪载体对所述防移位机构910-1进行示踪,就能够在光线的指引下,肉眼直观地观察到实体瘤所在的位置。In clinical use, the anti-displacement mechanism 910-1 is set in the delivery sheath 910-21, and under X-ray or MRI conditions, the delivery sheath 910-21 is inserted into the position of the solid tumor, and then the delivery sheath 910-21 is used to The pushing mechanism 910-22 pushes out the anti-displacement mechanism 910-1 and fixes it on the solid tumor, and then removes the delivery sheath 910-21 to stop and fix the anti-displacement mechanism 910-1 on the solid tumor In the operation, the light source 1 is turned on, and the optical tracer traces the anti-displacement mechanism 910-1, so that the position of the solid tumor can be visually observed with the naked eye under the guidance of the light. .
本发明之实体瘤示踪装置含防移位机构910-1、递送机构910-2、显影机构4和医用光学示踪系统500;所述医用光学示踪系统500对所述防移位机构910-1进行光学示踪。所述医用光学示踪系统500含光源1和光学示踪载体2。所述光源1发出的光经所述光学示 踪载体2进行传导后,对所述光学示踪载体2进行光学示踪。所述光源1也可以采用微型的所述LED光源11,将所述LED光源11的发光端11-1直接和所述光学示踪载体2设置成一个整体置入人体内,进行光学示踪。由于设计有所述医用光学示踪系统500,本发明之实体瘤示踪装置可以在进入人体后,通过可见光进行实体瘤的示踪,手术时,接通所述光源1,所述光学示踪载体2对所述防移位机构910-1进行示踪,就能够在光线的指引下,肉眼直观地观察到实体瘤所在的位置,临床手术更加安全、方便。The solid tumor tracking device of the present invention includes an anti-displacement mechanism 910-1, a delivery mechanism 910-2, a developing mechanism 4, and a medical optical tracing system 500; the medical optical tracing system 500 controls the displacement preventing mechanism 910 -1 for optical tracing. The medical optical tracer system 500 includes a light source 1 and an optical tracer carrier 2 . After the light emitted by the light source 1 is transmitted through the optical trace carrier 2, the optical trace carrier 2 is optically traced. The light source 1 can also use the miniature LED light source 11, and the light-emitting end 11-1 of the LED light source 11 is directly arranged with the optical tracer carrier 2 as a whole and put into the human body for optical tracer. Due to the design of the medical optical tracer system 500, the solid tumor tracer device of the present invention can trace solid tumors through visible light after entering the human body. During surgery, the light source 1 is turned on, and the optical tracer The carrier 2 traces the anti-displacement mechanism 910-1, so that the position of the solid tumor can be visually observed with the naked eye under the guidance of the light, and the clinical operation is safer and more convenient.
附图说明Description of drawings
图1是本发明之实体瘤示踪装置的定位钩收在递送鞘内的立体结构示意图。FIG. 1 is a three-dimensional structural schematic diagram of a solid tumor tracking device of the present invention with a positioning hook housed in a delivery sheath.
图1-1是图1的A-A剖视图。Fig. 1-1 is a sectional view of A-A in Fig. 1 .
图1-2是图1的A1处放大图。Figure 1-2 is an enlarged view of A1 in Figure 1.
图2是图1的定位钩推出时的结构示意图。Fig. 2 is a schematic diagram of the structure when the positioning hook of Fig. 1 is pushed out.
图2-1是图2的B-B剖视图。Fig. 2-1 is a B-B sectional view of Fig. 2 .
图2-2是图2的B1处放大图。Figure 2-2 is an enlarged view of B1 in Figure 2.
图2-3是图2-2的B2处放大图。Figure 2-3 is an enlarged view of B2 in Figure 2-2.
图2-4是图2的爆炸图。Figures 2-4 are exploded views of Figure 2.
图3是LED光源的发光端设置在定位钩上的结构示意图。Fig. 3 is a schematic diagram of the structure in which the light-emitting end of the LED light source is arranged on the positioning hook.
图3-1是图3的C1处放大图。Figure 3-1 is an enlarged view of C1 in Figure 3.
图4是含间断式开口套管的本发明之实体瘤示踪装置的结构示意图。Fig. 4 is a schematic structural view of the solid tumor tracking device of the present invention with an interrupted open sleeve.
图4-1是图4的D1处放大图。Figure 4-1 is an enlarged view of D1 in Figure 4.
图5是含多个实体瘤示踪装置的结构示意图。Fig. 5 is a schematic structural diagram of a tracking device containing multiple solid tumors.
图5-1是图5的爆炸图。Figure 5-1 is an exploded view of Figure 5.
图6是含球形防移位机构的本发明之实体瘤示踪装置的结构示意图。Fig. 6 is a schematic structural view of the solid tumor tracking device of the present invention with a spherical anti-displacement mechanism.
图6-1是图6的E-E剖视图。Fig. 6-1 is a sectional view along line E-E of Fig. 6 .
图6-2是图6-1的E1处放大图。Figure 6-2 is an enlarged view of E1 in Figure 6-1.
图7是含哑铃型防移位机构的本发明之实体瘤示踪装置的结构示意图。Fig. 7 is a schematic structural view of the solid tumor tracking device of the present invention with a dumbbell-shaped anti-displacement mechanism.
图7-1是图7的F1处放大图。Figure 7-1 is an enlarged view of F1 in Figure 7.
图7-2是图7的F-F剖视图。Fig. 7-2 is a sectional view of F-F in Fig. 7 .
图7-3是图7-2的F2处放大图。Figure 7-3 is an enlarged view of F2 in Figure 7-2.
图7-4是含涂层的哑铃型防移位机构。Figure 7-4 is a coated dumbbell-shaped anti-displacement mechanism.
图8是含螺旋型防移位机构的本发明之实体瘤示踪装置的结构示意图。Fig. 8 is a schematic structural view of the solid tumor tracking device of the present invention with a helical anti-displacement mechanism.
图8-1是图8的G1放大图。Figure 8-1 is an enlarged view of G1 in Figure 8.
图9是同时含螺旋型恒和哑铃型防移位机构的本发明之实体瘤示踪装置的结构示意图。Fig. 9 is a schematic structural view of the solid tumor tracking device of the present invention which includes both a helical constant and a dumbbell-shaped anti-displacement mechanism.
图9-1是图9的H1处放大图。Figure 9-1 is an enlarged view of H1 in Figure 9.
图10是含LED光源的本发明之实体瘤示踪装置的结构示意图。Fig. 10 is a schematic structural view of a solid tumor tracking device of the present invention including an LED light source.
图10-1是图10的递送机构撤除后的结构示意图。Fig. 10-1 is a schematic structural view of the delivery mechanism in Fig. 10 after being removed.
图11是含医用冷光源的本发明之实体瘤示踪装置的结构示意图。Fig. 11 is a schematic structural diagram of a solid tumor tracking device of the present invention including a medical cold light source.
图12是含蓄光自发光示踪载体的本发明之实体瘤示踪装置的结构示意图。Fig. 12 is a schematic structural diagram of a solid tumor tracking device of the present invention containing a light-storing self-luminescent tracking carrier.
图12-1是图12的I1处放大图。Figure 12-1 is an enlarged view of I1 in Figure 12.
图13是本发明之实体瘤示踪装置插入肺结节时的工作原理图。Fig. 13 is a schematic diagram of the working principle of the solid tumor tracking device of the present invention when it is inserted into a pulmonary nodule.
图13-1是图13撤除递送机构导光光纤连接光源后的工作原理图。Fig. 13-1 is a working principle diagram of Fig. 13 after the delivery mechanism is removed and the light-guiding fiber is connected to the light source.
上述图中:In the above figure:
500是医用光学示踪系统,910为本发明之实体瘤示踪装置。500 is a medical optical tracing system, and 910 is a solid tumor tracing device of the present invention.
1为光源,2为光学示踪载体,3为涂层,4为显影机构,5为保护套管。1 is a light source, 2 is an optical tracer carrier, 3 is a coating, 4 is a developing mechanism, and 5 is a protective sleeve.
11为LED光源,12为医用冷光源,13为控制系统,11-1为发光端,11-2为电路系统,11-3为驱动板,11-4为电源,13-1为波长调节机构,13-2为光强调节机构,11-21为柔性电路板。11 is the LED light source, 12 is the medical cold light source, 13 is the control system, 11-1 is the light-emitting terminal, 11-2 is the circuit system, 11-3 is the drive board, 11-4 is the power supply, 13-1 is the wavelength adjustment mechanism , 13-2 is a light intensity adjustment mechanism, and 11-21 is a flexible circuit board.
21为蓄光自发光示踪载体,22为导光光纤,26为导光接头;21-1为蓄光自发光体,21-2为保护载体;22-1为非光滑的表面,22-2为出光口;22-11为能形成反射、和/或散射的非光滑表面,22-21为传导面,22-22为反射面。21 is a light-storage self-illumination tracer carrier, 22 is a light-guiding optical fiber, and 26 is a light-guiding joint; 21-1 is a light-storage self-illumination body, and 21-2 is a protection carrier; 22-1 is a non-smooth surface, and 22-2 is a Light outlet: 22-11 is a non-smooth surface capable of forming reflection and/or scattering, 22-21 is a conductive surface, and 22-22 is a reflective surface.
910-1为防移位机构,910-2为递送机构;910-11为定位钩,910-21为递送鞘,910-22为推送机构。910-1 is an anti-displacement mechanism, 910-2 is a delivery mechanism; 910-11 is a positioning hook, 910-21 is a delivery sheath, and 910-22 is a pushing mechanism.
具体实施方式Detailed ways
实施例1:本发明之实体瘤示踪装置Embodiment 1: The solid tumor tracking device of the present invention
参考图1至图5-1,本实施例之含防移位机构910-1、递送机构910-2、显影机构4和医用光学示踪系统500,所述医用光学示踪系统500对所述防移位机构910-1进行光学示踪。Referring to Fig. 1 to Fig. 5-1, the anti-displacement mechanism 910-1, the delivery mechanism 910-2, the developing mechanism 4 and the medical optical tracer system 500 in this embodiment, the medical optical tracer system 500 is for the described The anti-displacement mechanism 910-1 performs optical tracking.
所述防移位机构910-1可以固定在需要被标定的实体瘤上,以防止所述实体瘤示踪装置910随着人体运动,如肺部呼吸运动、肠道蠕动、胃部蠕动等而移位。The anti-displacement mechanism 910-1 can be fixed on the solid tumor that needs to be calibrated, so as to prevent the solid tumor tracking device 910 from moving with the movement of the human body, such as lung breathing movement, intestinal peristalsis, gastric peristalsis, etc. shift.
所述光源1发出的光线的颜色可以根据背景颜色或穿透要求进行设置。通过光线的设置,在临床手术中,医生可以直接通过肉眼透过组织看到所述光学示踪载体2所在的位置, 进而准确辨别临床手术中,需要重点保护的血管、组织或器官,有效避免手术过程中的意外伤害。所述光源1发出的光线可以根据体腔内的背景颜色或需要穿透的组织进行差异化设置,当需要穿透组织时,红色和黄色为佳,紫色和白色次之。The color of light emitted by the light source 1 can be set according to background color or penetration requirements. Through the setting of light, in clinical operations, doctors can directly see the position of the optical tracer carrier 2 through the tissue with the naked eye, and then accurately identify the blood vessels, tissues or organs that need to be protected during clinical operations, effectively avoiding Accidental injury during surgery. The light emitted by the light source 1 can be differentiated according to the background color in the body cavity or the tissue to be penetrated. When the tissue needs to be penetrated, red and yellow are the best, followed by purple and white.
所述光源1是闪烁型发光。所述光源1还可以可以根据需要设置成间断点亮、闪烁等形式。The light source 1 is a flashing type of light emitting. The light source 1 can also be set to intermittent lighting, flashing, etc. as required.
所述光源1发出的光线的强度可以进行设置。所述光源1发出的光线的强度也可以根据需要进行调整,以适应不同的临床环境。所述光源1发出的光线的照度可达30万lux,较佳范围在5千lux至15万lux。The intensity of light emitted by the light source 1 can be set. The intensity of the light emitted by the light source 1 can also be adjusted as required to adapt to different clinical environments. The illuminance of the light emitted by the light source 1 can reach 300,000 lux, preferably ranging from 5,000 lux to 150,000 lux.
参考图10和图11,所述光源1含控制系统13,所述控制系统13含波长调节机构13-1和光强调节机构13-2,所述波长调节机构13-1能通过波长的调节来调节发出的光线的颜色,所述光强调节机构13-2,能调节发出的光线的照度。10 and 11, the light source 1 includes a control system 13, the control system 13 includes a wavelength adjustment mechanism 13-1 and a light intensity adjustment mechanism 13-2, and the wavelength adjustment mechanism 13-1 can adjust the wavelength To adjust the color of the emitted light, the light intensity adjustment mechanism 13-2 can adjust the illuminance of the emitted light.
参考图1至图5-1,本实施例中,所述防移位机构910-1工作状态时呈钩状结构,含2个定位钩910-11。Referring to Fig. 1 to Fig. 5-1, in this embodiment, the anti-displacement mechanism 910-1 is in a hook-shaped structure in working state, and includes two positioning hooks 910-11.
通常,所述防移位机构910-1含2个或3个所述定位钩910-11,以更好地防止所述防移位机构910-1随着人体的运动,如肺部的呼吸运动、肠道的蠕动等而发生移位。Usually, the anti-displacement mechanism 910-1 includes 2 or 3 positioning hooks 910-11 to better prevent the anti-displacement mechanism 910-1 from moving with the human body, such as the breathing of the lungs. Displacement occurs due to movement, intestinal peristalsis, etc.
实际应用中,所述防移位机构910-1工作状态时还可以是球形结构(参考图6至图6-2)、喇叭形结构、和/或哑铃型结构(参考图7至图7-3,图9和图9-1)、和/或螺旋弹簧型结构(参考图8和图8-1,图9和图9-1)、和/或钉状结构。申请人在此只举例说明了上述几种结构的所述防移位机构910-1的方式,实际应用中,本领域的技术人员可以根据需要设计出不同结构的所述防移位机构910-1,申请人在此不一一举例说明,但都不脱离本申请的保护范围。In practical applications, the anti-displacement mechanism 910-1 can also be a spherical structure (refer to FIG. 6 to FIG. 6-2 ), a horn-shaped structure, and/or a dumbbell-shaped structure (refer to FIG. 7 to FIG. 3, Figure 9 and Figure 9-1), and/or a helical spring structure (refer to Figure 8 and Figure 8-1, Figure 9 and Figure 9-1), and/or a nail-like structure. The applicant here only exemplifies the manners of the anti-displacement mechanism 910-1 with the above-mentioned several structures. In practical applications, those skilled in the art can design the anti-displacement mechanism 910-1 with different structures as required 1. The applicant does not give examples one by one here, but they all do not depart from the protection scope of the present application.
所述防移位机构910-1可以由形状记忆合金制造,在体外时呈线性结构,进入人体后在体温的作用下恢复成设定的钩状结构、和/或喇叭形结构、和/或哑铃型结构、和/或螺旋弹簧型结构、和/或钉状结构。The anti-displacement mechanism 910-1 can be made of shape memory alloy, which has a linear structure outside the body, and returns to the set hook-shaped structure and/or trumpet-shaped structure under the action of body temperature after entering the human body, and/or A dumbbell-shaped structure, and/or a helical spring-shaped structure, and/or a spike-shaped structure.
本实施例中,所述防移位机构910-1由显影材料制成,构成所述显影机构4,在X光下、和/或MRI下、和/或B超下进行显影。临床使用时,在X光下、和/或MRI下、和/或B超下,所述防移位机构910-1被置入需要标定的肿瘤组织内。In this embodiment, the anti-displacement mechanism 910-1 is made of a developing material, which constitutes the developing mechanism 4, and develops under X-ray and/or MRI and/or B-ultrasound. In clinical use, under X-ray, and/or MRI, and/or B-ultrasound, the anti-displacement mechanism 910-1 is placed in the tumor tissue that needs to be marked.
所述递送机构910-2含推送机构910-21和递送鞘管910-22。The delivery mechanism 910-2 includes a push mechanism 910-21 and a delivery sheath 910-22.
参考图1和图1-1,所述防移位机构910-1被设置在所述递送鞘管910-22内,所述推送机构910-21能将所述防移位机构910-1从所述递送鞘管910-22内推出置入实体瘤内。Referring to Fig. 1 and Fig. 1-1, the anti-displacement mechanism 910-1 is set in the delivery sheath 910-22, and the pushing mechanism 910-21 can push the anti-displacement mechanism 910-1 from The delivery sheath 910-22 is pushed out and placed into a solid tumor.
所述推送机构910-22可以和所述防移位机构910-1固定连接,将所述防移位机构910-1从所述递送鞘910-21中推出后一起停留在体内;所述推送机构910-22也可以和所述防移 位机构910-1可拆卸连接,将所述防移位机构910-1从所述递送鞘910-21中推出后,和所述防移位机构910-1解除连接,只将所述防移位机构910-1留置在实体瘤处。The pushing mechanism 910-22 can be fixedly connected with the anti-displacement mechanism 910-1, and stay in the body together after the anti-displacement mechanism 910-1 is pushed out from the delivery sheath 910-21; The mechanism 910-22 can also be detachably connected with the anti-displacement mechanism 910-1, after the anti-displacement mechanism 910-1 is pushed out from the delivery sheath 910-21, and the anti-displacement mechanism 910 - 1 Disconnect, and only place the anti-displacement mechanism 910-1 on the solid tumor.
所述医用光学示踪系统500含光源1和光学示踪载体2。The medical optical tracer system 500 includes a light source 1 and an optical tracer carrier 2 .
所述光学示踪载体2含导光材料,所述光源1发出的光经所述光学示踪载体2进行传导,并对所述光学示踪载体2进行光学示踪。The optical tracer carrier 2 contains a light-guiding material, and the light emitted by the light source 1 is conducted through the optical tracer carrier 2 and optically traces the optical tracer carrier 2 .
所述光学示踪载体2能对所述移位机构910-1进行光学示踪。The optical tracking carrier 2 can perform optical tracking on the displacement mechanism 910-1.
参考图10至图11,所述光源1可以是LED光源11、和/或医用冷光源12、和/或自然光。所述光源1可以是各种能发出光线的光源,所述光源1发出的光线可以经所述光学示踪载体1传导后进行示踪。所述LED光源11与普通照明光源相比,具有体积小、发光效率高、光源指向性强等特点,尤其是在安全性方面,LED光源有普通光源无法比拟的优势。首先LED光源是低压直流供电,供电电压只需6到24V;其次LED光源中不添加汞,不会对人体造成中毒等伤害;此外更重要的是LED光源是冷光源,在工作过程中不会严重发热,可以安全触摸,不会对人体造成意外的高温烫伤。所述医用冷光源12是现有手术过程中的常用光源,而且可以将所述光源1后置,手术室中容易获得,不需要额外的设备。10 to 11, the light source 1 may be an LED light source 11, and/or a medical cold light source 12, and/or natural light. The light source 1 can be various light sources capable of emitting light, and the light emitted by the light source 1 can be traced after being transmitted through the optical trace carrier 1 . Compared with ordinary lighting sources, the LED light source 11 has the characteristics of small size, high luminous efficiency, and strong light source directivity. Especially in terms of safety, LED light sources have incomparable advantages over ordinary light sources. First of all, the LED light source is a low-voltage DC power supply, and the power supply voltage only needs to be 6 to 24V; secondly, no mercury is added to the LED light source, which will not cause poisoning or other harm to the human body; more importantly, the LED light source is a cold light source, which will not cause harm to the human body during work. Severe heat, safe to touch, will not cause unexpected high temperature burns to the human body. The medical cold light source 12 is a commonly used light source in the existing operation process, and the light source 1 can be placed behind, which is easy to obtain in the operating room and does not require additional equipment.
本实施例中,所述光源1是所述LED光源11。In this embodiment, the light source 1 is the LED light source 11 .
所述LED光源11可以设置在体内,也可以设置在体外。由于所述LED光源11的发光端11-1的体积可以非常小,通常所述发光端11-1大小控制在2mm以下,如封装尺寸在0.2mm~0.5mm之间的LED灯,因此,所述LED光源11不但能设置在体外,通过所述光学示踪载体2向人体内进行光线传导,而且可以直接设置在人体内,外部包覆所述光学示踪载体2,直接设置在需要示踪的部位。The LED light source 11 can be arranged inside the body, or outside the body. Since the volume of the light-emitting end 11-1 of the LED light source 11 can be very small, usually the size of the light-emitting end 11-1 is controlled below 2 mm, such as an LED lamp with a package size between 0.2 mm and 0.5 mm. Therefore, the The above-mentioned LED light source 11 can not only be installed outside the body, and conduct light transmission into the human body through the optical tracer carrier 2, but also can be directly installed in the human body, coated with the optical tracer carrier 2, and directly arranged in the place where tracer is required. parts.
当所述LED光源11设置在体外时,所述光学示踪载体2是导光光纤22。所述导光光纤22具有良好的导光效果,并根据需要将光线传导至各个不同的位置,而且可以根据需要接通或切断,临床使用非常方便。When the LED light source 11 is placed outside the body, the optical trace carrier 2 is a light guiding fiber 22 . The light-guiding optical fiber 22 has a good light-guiding effect, and guides the light to different positions as required, and can be switched on or off as required, which is very convenient for clinical use.
参考图2和图4,本实施例中,所述导光光纤22具有非光滑的表面22-1。Referring to FIG. 2 and FIG. 4 , in this embodiment, the light guiding fiber 22 has a non-smooth surface 22 - 1 .
所述非光滑的表面22-1是能形成反射、和/或散射的非光滑表面22-11。可以实现所述非光滑的表面22-1的整体发光,达到整体示踪的效果。The non-smooth surface 22-1 is a non-smooth surface 22-11 capable of forming reflection and/or scattering. The overall luminescence of the non-smooth surface 22-1 can be realized to achieve the effect of overall tracking.
所述导光光纤22上间断式设置有出光口22-2。间断式设置的每个所述出光口22-2具有光线的传导面22-21和反射面22-22,光线经所述传导面22-21进行传导,至所述反射面22-22时,光线发生反射,从所述出光口22-2射出,形成一个示踪点,多个所述出光口22-2可形成链状示踪带。所述导光光纤22可通过保护套管5固定在所述防移位机构910-1上,参考图。The light-guiding optical fiber 22 is intermittently provided with a light outlet 22-2. Each of the light outlets 22-2 provided intermittently has a light transmission surface 22-21 and a reflection surface 22-22, the light is transmitted through the transmission surface 22-21, and when it reaches the reflection surface 22-22, The light is reflected and emitted from the light outlet 22-2 to form a tracer point, and a plurality of the light outlets 22-2 can form a chain tracer strip. The light guiding fiber 22 can be fixed on the anti-displacement mechanism 910-1 through the protective sleeve 5, refer to the figure.
所述导光光纤22还可以编织成网状,不同位置散落状分布有出光口22-2。所述导光光 纤22编织成网状,可以通过将每一根所述导光光纤22的长度设置成不同,所述导光光纤22的出光口22-2也随之不同,散落分布,可实现立体空间的整体示踪,由于每一根所述导光光纤22中间不需要设置所述出光口22-1,因此光线传导效果更好,单个示踪点的视觉效果非常明亮。也可以将侧面设置有所述出光口22-2,能整体点亮的所述导光光纤22编织成网状,实现整个所述防移位机构910-1的全面积示踪。The light-guiding optical fiber 22 can also be woven into a net shape, and the light outlets 22-2 are scattered in different positions. The light-guiding optical fiber 22 is braided into a net shape, and the length of each of the light-guiding optical fibers 22 can be set to be different, and the light outlets 22-2 of the light-guiding optical fiber 22 are also different thereupon, scattered and distributed, which can be To realize the overall tracking in the three-dimensional space, since the light outlet 22-1 does not need to be arranged in the middle of each light-guiding optical fiber 22, the light transmission effect is better, and the visual effect of a single tracking point is very bright. It is also possible to weave the light-guiding optical fiber 22 that is provided with the light outlet 22-2 on the side and can be illuminated as a whole into a net shape, so as to realize full-area tracking of the entire anti-displacement mechanism 910-1.
参考图7-4,所述导光光纤22表面可以设有涂层3。所述涂层3可以根据需要进行设计不同性质的涂层,如抗凝涂层、亲水涂层或疏水涂层。Referring to FIG. 7-4 , the surface of the light guiding fiber 22 may be provided with a coating 3 . The coating 3 can be designed with different properties as required, such as anticoagulation coating, hydrophilic coating or hydrophobic coating.
当所述防移位机构910-1采用非显影材料制造时,也可以在所述光学示踪载体2上设置所述显影机构4,所述显影机构4在X光下、和/或MRI下、和/或B超下进行显影。所述显影机构4可以是显影线41、和/或显影环42、和/或显影块43等。申请人在此只举例说明了上述几种显影方式,实际应用中,本领域的技术人员可以根据需要设计出不同的显影方式,申请人在此不一一举例说明,但都不脱离本申请的保护范围。所述显影机构4在X光、磁导航、或B超等场景下能进行显影提示,所述显影机构4便于所述光学示踪载体2能在可视或导航的情况下被置入肿瘤组织内,参考图**。When the anti-displacement mechanism 910-1 is made of non-developing material, the developing mechanism 4 can also be arranged on the optical tracer carrier 2, and the developing mechanism 4 can be used under X-ray and/or MRI , and/or develop under B-ultrasound. The developing mechanism 4 may be a developing line 41, and/or a developing ring 42, and/or a developing block 43, and the like. The applicant here only exemplifies the above-mentioned several developing methods. In practical applications, those skilled in the art can design different developing methods according to needs. The applicant does not give examples here, but they do not deviate from the scope of the application protected range. The development mechanism 4 can perform development prompts in X-ray, magnetic navigation, or B-ultrasound scenarios, and the development mechanism 4 facilitates the optical tracking carrier 2 to be placed into the tumor tissue under the condition of visualization or navigation Inside, refer to Fig.**.
所述光学示踪载体2由柔顺的医用材料制成,设置在所述防移位机构910-1的外表面。The optical trace carrier 2 is made of flexible medical material, and is arranged on the outer surface of the anti-displacement mechanism 910-1.
本实施例中,所述导光光纤22的近端与导光接头26连接,所述导光光纤22的远端连接、固定在所述防移位机构910-1上,所述导光光纤22的出光口22-2设置在所述防移位机构910-1上。In this embodiment, the proximal end of the light guiding fiber 22 is connected to the light guiding connector 26, the far end of the light guiding fiber 22 is connected and fixed on the anti-displacement mechanism 910-1, the light guiding fiber The light outlet 22-2 of 22 is set on the anti-displacement mechanism 910-1.
参考图2至图2-3,所述导光光纤22由柔顺的医用材料制成,连接固定在所述防移位机构910-1上,当所述防移位机构910-1发生变形时,所述导光光纤22随着所述防移位机构910-1发生变形。由于所述导光光纤22能整体点亮,因此,将所述导光光纤22缠绕在所述防移位机构910-1上,尤其是所述定位钩910-11上,就可以随着所述防移位机构910-1一起发生变形,尤其是当所述防移位机构910-1采用形状记忆合金制造时,随着所述防移位机构910-1的形状发生变化,所述导光光纤22的形状也随之发生变化,保证对所述防移位机构910-1的示踪效果。Referring to Fig. 2 to Fig. 2-3, the light guide fiber 22 is made of flexible medical material, connected and fixed on the anti-displacement mechanism 910-1, when the anti-displacement mechanism 910-1 is deformed , the light guiding fiber 22 is deformed along with the anti-displacement mechanism 910-1. Since the light guiding fiber 22 can be lighted as a whole, winding the light guiding fiber 22 on the anti-displacement mechanism 910-1, especially on the positioning hook 910-11, can follow the The anti-displacement mechanism 910-1 is deformed together, especially when the anti-displacement mechanism 910-1 is made of shape memory alloy, as the shape of the anti-displacement mechanism 910-1 changes, the guide The shape of the optical fiber 22 also changes accordingly to ensure the tracking effect of the anti-displacement mechanism 910-1.
当所述LED光源11采用微型设计时,所述LED光源11含发光端11-1和电路系统11-2。所述发光端11-1可以设置在体内。When the LED light source 11 adopts a miniature design, the LED light source 11 includes a light-emitting terminal 11-1 and a circuit system 11-2. The light-emitting end 11-1 can be set inside the body.
此时,所述光学示踪载体2由透明材料制成,所述LED光源11的发光端11-1可以封装在所述光学示踪载体2上,与所述光学示踪载体2一起设置在所述防移位机构910-1上,对所述防移位机构910-1进行示踪。At this time, the optical trace carrier 2 is made of a transparent material, and the light-emitting end 11-1 of the LED light source 11 can be packaged on the optical trace carrier 2, and is set together with the optical trace carrier 2 On the anti-displacement mechanism 910-1, trace the anti-displacement mechanism 910-1.
所述发光端11-1发出的光线经所述光学示踪载体2的导光材料传导后显示,供临床辨别实体瘤的位置。The light emitted from the light-emitting end 11-1 is displayed after being transmitted through the light-guiding material of the optical tracer carrier 2, for clinically identifying the position of a solid tumor.
参考图3和图3-1以及图7至图7-3,所述LED光源11含发光端11-1、电路系统11-2、驱动板11-3和电源11-4;所述发光端11-1通过所述电路系统11-2和所述驱动板11-3及所述电源11-4连接,在所述驱动板11-3的控制下,所述电源11-4通过所述电路系统11-2对所述发光端11-1供电,所述发光端11-1发出光线;所述驱动板11-3及所述电源11-4设置在体外,所述发光端11-1设置在体内,对所述防移位机构910-1进行示踪。Referring to Fig. 3 and Fig. 3-1 and Fig. 7 to Fig. 7-3, the LED light source 11 includes a light-emitting terminal 11-1, a circuit system 11-2, a driving board 11-3 and a power supply 11-4; the light-emitting terminal 11-1 is connected to the drive board 11-3 and the power supply 11-4 through the circuit system 11-2, and under the control of the drive board 11-3, the power supply 11-4 passes through the circuit The system 11-2 supplies power to the light-emitting end 11-1, and the light-emitting end 11-1 emits light; the driving board 11-3 and the power supply 11-4 are arranged outside the body, and the light-emitting end 11-1 In vivo, the anti-displacement mechanism 910-1 is tracked.
所述电路系统11-2是柔性电路板11-21,所述LED光源11的发光端11-1分散设置在所述柔性电路板11-21上并封装在所述光学示踪载体2内,构成LED灯带、或LED灯网、或LED灯球,设置在所述防移位机构910-1上,对所述防移位机构910-1进行示踪。The circuit system 11-2 is a flexible circuit board 11-21, and the light emitting ends 11-1 of the LED light source 11 are dispersedly arranged on the flexible circuit board 11-21 and packaged in the optical tracer carrier 2, It constitutes an LED light strip, or an LED light net, or an LED light ball, and is arranged on the anti-displacement mechanism 910-1 to track the anti-displacement mechanism 910-1.
所述LED光源11可以是采用单个所述发光端11-1封装后进行定点示踪,也可以是将所述电路系统11-2采用柔性电路板11-21,所述发光端11-1分散地设置在所述柔性电路板11-21的任何位置,从而形成发光带,将光带缠绕在所述防移位机构910-1上,或将多条所述LED光源11与所述光学示踪载体2一起封装成网状、球状等形状,对所述防移位机构910-1进行整体示踪。The LED light source 11 can be packaged with a single light-emitting terminal 11-1 for fixed-point tracing, or the circuit system 11-2 can be used with a flexible circuit board 11-21, and the light-emitting terminals 11-1 can be dispersed be arranged at any position of the flexible circuit board 11-21 to form a light strip, and the light strip is wound on the anti-displacement mechanism 910-1, or a plurality of the LED light sources 11 and the optical display The tracking carrier 2 is packaged together into a shape such as a mesh or a ball, and the overall tracking of the anti-displacement mechanism 910-1 is carried out.
所述LED光源11的发光端11-1还可以直接设置在所述防移位机构910-1上,外部包覆透明材料制成的所述光学示踪载体2,所述发光端11-1发出的光线对所述防移位机构910-1进行示踪。The light-emitting end 11-1 of the LED light source 11 can also be directly arranged on the anti-displacement mechanism 910-1, and the optical trace carrier 2 made of transparent material is coated on the outside, and the light-emitting end 11-1 The emitted light traces the anti-displacement mechanism 910-1.
所述发光端11-1可以直接设置在所述防移位机构910-1上,然后外部包覆透明材料制成的所述光学示踪载体2,这样所述发光端11-1就可以完整地贴合所述防移位机构910-1的外部轮廓,对所述防移位机构910-1形状任何形状的示踪。The light-emitting end 11-1 can be directly arranged on the anti-displacement mechanism 910-1, and then the optical tracer carrier 2 made of transparent material is coated on the outside, so that the light-emitting end 11-1 can be completely It fits the outer contour of the anti-displacement mechanism 910-1 accurately, and traces any shape of the anti-displacement mechanism 910-1.
此外,所述发光端11-1对称设置,外部包覆所述光学示踪载体2,利用所述发光端11-1和所述电路系统11-2的内部支撑和所述发光端11-1的自身体积,可构成所述防移位机构910-1,所述医用光学示踪系统500可以同时兼具示踪功能和所述防移位机构910-1的定位功能,参考图7至图7-4。In addition, the light-emitting end 11-1 is arranged symmetrically, and the outside covers the optical tracer carrier 2, and the internal support of the light-emitting end 11-1 and the circuit system 11-2 and the light-emitting end 11-1 Its own volume can constitute the anti-displacement mechanism 910-1, and the medical optical tracer system 500 can have both the tracing function and the positioning function of the anti-displacement mechanism 910-1, refer to Fig. 7 to Fig. 7-4.
所述电路系统11-2是柔性电路板11-21,所述光学示踪载体2由柔软的透明材料制成,所述发光端11-1、所述柔性电路板11-21和显影机构4一起设置在所述光学示踪载体2内,并设置在所述防移位机构910-1上,当所述防移位机构910-1发生变形时,所述发光端11-1、所述柔性电路板11-21、所述显影机构4和所述光学示踪载体2一起随着所述防移位机构910-1发生变形。尤其是当所述防移位机构910-1采用形状记忆合金制造时,随着所述防移位机构910-1的形状发生变化,所述柔性电路板11-21的形状也随之发生变化,保证对所述防移位机构910-1的示踪效果。The circuit system 11-2 is a flexible circuit board 11-21, the optical trace carrier 2 is made of soft transparent material, the light-emitting terminal 11-1, the flexible circuit board 11-21 and the developing mechanism 4 They are arranged together in the optical trace carrier 2 and on the anti-displacement mechanism 910-1. When the anti-displacement mechanism 910-1 is deformed, the light-emitting end 11-1, the The flexible circuit board 11 - 21 , the developing mechanism 4 and the optical trace carrier 2 are deformed together with the anti-displacement mechanism 910 - 1 . Especially when the anti-displacement mechanism 910-1 is made of shape memory alloy, as the shape of the anti-displacement mechanism 910-1 changes, the shape of the flexible circuit board 11-21 also changes accordingly. , to ensure the tracking effect on the anti-displacement mechanism 910-1.
参考图12和图12-1,所述光学示踪载体2是蓄光自发光示踪载体21。自发光材料是指能够以某种方式吸收能量,将其转化成非平衡光辐射的物质材料,材料内部吸收的能量 转化为非平衡光辐射的过程就是发光过程。尤其是蓄光自发光材料在外界光照作用下几分钟或几十分钟之后,在黑暗的环境下可持续发光12小时以上,可以满足大多数手术时长的示踪需求。所述蓄光自发光示踪载体21可以直接吸收手术室中灯光的能量,使得各种外部光照都能构成所述光源1,不需要直接连接所述光源1,使用过程非常简单。Referring to FIG. 12 and FIG. 12-1 , the optical trace carrier 2 is a light-storing self-luminous trace carrier 21 . Self-luminous materials refer to materials that can absorb energy in a certain way and convert it into non-equilibrium light radiation. The process of converting the energy absorbed inside the material into non-equilibrium light radiation is the luminescence process. In particular, light-storing self-luminescent materials can continue to emit light for more than 12 hours in a dark environment after a few minutes or tens of minutes under the action of external light, which can meet the tracing needs of most operations. The light-storing self-illuminating tracer carrier 21 can directly absorb the energy of the light in the operating room, so that various external lights can form the light source 1, and there is no need to directly connect the light source 1, and the use process is very simple.
所述蓄光自发光示踪载体21含蓄光自发光体21-1和保护载体21-2。The light-storage self-luminous tracer carrier 21 includes a light-storage self-illuminator 21-1 and a protection carrier 21-2.
所述保护载体21-2由透明导光材料制成,所述蓄光自发光体21-1封闭设置在所述保护载体21-2内。The protective carrier 21-2 is made of a transparent light-guiding material, and the light-storing self-luminous body 21-1 is closed and arranged in the protective carrier 21-2.
所述蓄光自发光体21-1能吸收外部能量,并进行转化发光。所述保护载体21-2采用透明医用材料制成,可以直接和组织进行接触,所述蓄光自发光体21-1能量转化发出的光能有效透过进行有效示踪的同时,还保证了临床使用的生物安全性。所述蓄光自发光体21-1能设置在不同的位置,并设计成不同形状,根据需要进行定点示踪或进行整体示踪。The light-storing self-luminous body 21-1 can absorb external energy and convert it into light. The protective carrier 21-2 is made of transparent medical materials, which can be directly in contact with tissues. The light energy converted from the light-storing self-illuminating body 21-1 effectively passes through for effective tracing, and at the same time ensures clinical Biosafety used. The light-storing self-illuminating body 21-1 can be arranged in different positions and designed in different shapes, and can perform fixed-point tracking or overall tracking as required.
参考图13,临床应用时,当需要对肺肿瘤(尤其是肺结节)、或肝肿瘤等进行标定时,所述防移位机构910-1设置在所述递送鞘910-21内,在X光状态下,所述递送鞘910-21插入实体瘤所在的位置,然后用所述推送机构910-22将所述防移位机构910-1推出,固定在肺肿瘤(尤其是肺结节)、或肝肿瘤等实体瘤上,然后撤除所述递送鞘910-21,将所述防移位机构910-1停留、固定在实体瘤上,再将所述导光光纤22连接到所述光源1上,参考图13-1,手术时,接通所述光源1,所述光学示踪载体2对所述防移位机构910-1进行示踪,就能够在光线的指引下,肉眼直观地观察到肺肿瘤(尤其是肺结节)、或肝肿瘤等实体瘤所在的位置。Referring to FIG. 13 , in clinical application, when lung tumors (especially lung nodules) or liver tumors need to be calibrated, the anti-displacement mechanism 910-1 is set in the delivery sheath 910-21, and Under the X-ray state, the delivery sheath 910-21 is inserted into the position of the solid tumor, and then the anti-displacement mechanism 910-1 is pushed out by the pushing mechanism 910-22, and fixed on the lung tumor (especially the lung nodule). ), or liver tumors and other solid tumors, and then remove the delivery sheath 910-21, stay and fix the anti-displacement mechanism 910-1 on the solid tumor, and then connect the light-guiding optical fiber 22 to the On the light source 1, refer to Figure 13-1. During the operation, the light source 1 is turned on, and the optical tracer carrier 2 traces the anti-displacement mechanism 910-1, so that under the guidance of light, the naked eye can see Visually observe the location of lung tumors (especially lung nodules), or solid tumors such as liver tumors.
临床应用中,如需要对子宫肌瘤进行标定,可在B超引导下,将所述防移位机构910-1递送至子宫肌瘤处,固定在子宫肌瘤上,手术时,接通所述光源1,所述光学示踪载体2对所述防移位机构910-1进行示踪,就能够在光线的指引下,肉眼直观地观察到子宫肌瘤所在的位置。In clinical application, if it is necessary to calibrate the uterine fibroids, under the guidance of B-ultrasound, the anti-displacement mechanism 910-1 can be delivered to the uterine fibroids and fixed on the uterine fibroids. The light source 1 and the optical tracer 2 trace the anti-displacement mechanism 910-1, so that the position of the uterine fibroids can be visually observed with the naked eye under the guidance of the light.
本实施例之实体瘤示踪装置由于设计有所述医用光学示踪系统500,本发明之实体瘤示踪装置可以在进入人体后,通过可见光进行实体瘤的示踪,手术时,接通所述光源1,所述光学示踪载体对所述防移位机构910-1进行示踪,就能够在光线的指引下,肉眼直观地观察到实体瘤所在的位置,临床手术更加安全、方便。The solid tumor tracking device of this embodiment is designed with the medical optical tracking system 500. The solid tumor tracking device of the present invention can track solid tumors through visible light after entering the human body. The light source 1 and the optical tracer carrier trace the anti-displacement mechanism 910-1, so that the position of the solid tumor can be visually observed with the naked eye under the guidance of the light, and the clinical operation is safer and more convenient.
应该注意,本文中公开和说明的结构可以用其它效果相同的结构代替,同时本发明所介绍的实施例并非实现本发明的唯一结构。虽然本发明的优先实施例已在本文中予以介绍和说明,但本领域内的技术人员都清楚知道这些实施例不过是举例说明而已,本领域内的技术人员可以做出无数的变化、改进和代替,而不会脱离本发明,因此,应按照本发明所附的权利要求书的精神和范围来限定本发明的保护范围。It should be noted that the structures disclosed and described herein can be replaced by other structures with the same effect, and the embodiments described in the present invention are not the only structures for realizing the present invention. Although preferred embodiments of the present invention have been described and described herein, it is clear to those skilled in the art that these embodiments are for illustration only, and that numerous changes, modifications and improvements can be made by those skilled in the art. Instead, without departing from the present invention, therefore, the protection scope of the present invention should be defined according to the spirit and scope of the appended claims of the present invention.

Claims (37)

  1. 实体瘤示踪装置,其特征在于:所述实体瘤示踪装置(910)含医用光学示踪系统(500);所述医用光学示踪系统(500)置入实体瘤中,并通过可见光示踪技术对实体瘤进行位置标识。The solid tumor tracking device is characterized in that: the solid tumor tracking device (910) includes a medical optical tracking system (500); Tracking technology for location identification of solid tumors.
  2. 根据权利要求1所述实体瘤示踪装置,其特征在于:所述实体瘤示踪装置(910)含显影机构(4)。The solid tumor tracking device according to claim 1, characterized in that: the solid tumor tracking device (910) includes a developing mechanism (4).
  3. 根据权利要求1所述实体瘤示踪装置,其特征在于:所述实体瘤示踪装置(910)含防移位机构(910-1)。The solid tumor tracking device according to claim 1, characterized in that: the solid tumor tracking device (910) includes an anti-displacement mechanism (910-1).
  4. 根据权利要求1所述实体瘤示踪装置,其特征在于:所述实体瘤示踪装置(910)含递送机构(910-2)。The solid tumor tracking device according to claim 1, characterized in that: the solid tumor tracking device (910) comprises a delivery mechanism (910-2).
  5. 根据权利要求1所述实体瘤示踪装置,其特征在于:所述防移位机构(910-1)工作状态时呈钩状结构、和/或喇叭形结构、和/或哑铃型结构、和/或螺旋弹簧型结构、和/或钉状结构。The solid tumor tracking device according to claim 1, characterized in that: the anti-displacement mechanism (910-1) has a hook-shaped structure, and/or a horn-shaped structure, and/or a dumbbell-shaped structure, and /or helical spring-type structure, and/or nail-like structure.
  6. 根据权利要求5所述实体瘤示踪装置,其特征在于:所述防移位机构(910-1)呈钩状结构,至少含1个定位钩(910-11)。The solid tumor tracking device according to claim 5, characterized in that: the anti-displacement mechanism (910-1) has a hook-like structure and includes at least one positioning hook (910-11).
  7. 根据权利要求6所述实体瘤示踪装置,其特征在于:所述防移位机构(910-1)含2个定位钩(910-11)。The solid tumor tracking device according to claim 6, characterized in that: the anti-displacement mechanism (910-1) includes two positioning hooks (910-11).
  8. 根据权利要求6所述实体瘤示踪装置,其特征在于:所述防移位机构(910-1)由形状记忆合金制造,在体外时呈线性结构,进入人体后在体温的作用下恢复成设定的钩状结构、和/或喇叭形结构、和/或哑铃型结构、和/或螺旋弹簧型结构、和/或钉状结构。The solid tumor tracking device according to claim 6, characterized in that: the anti-displacement mechanism (910-1) is made of a shape memory alloy, which has a linear structure outside the body, and returns to a shape under the action of body temperature after entering the human body. The set hook-shaped structure, and/or trumpet-shaped structure, and/or dumbbell-shaped structure, and/or coil spring-shaped structure, and/or nail-shaped structure.
  9. 根据权利要求1所述实体瘤示踪装置,其特征在于:所述防移位机构(910-1)由显影材料制成,构成所述显影机构(4),在X光下、和/或MRI下、和/或B超下进行显影。The solid tumor tracking device according to claim 1, characterized in that: the anti-displacement mechanism (910-1) is made of a developing material, constituting the developing mechanism (4), under X-ray, and/or Develop under MRI and/or B-ultrasound.
  10. 根据权利要求1所述实体瘤示踪装置,其特征在于:所述递送机构(910-2)含推送机构(910-21)和递送鞘管(910-22)。The solid tumor tracking device according to claim 1, characterized in that: the delivery mechanism (910-2) comprises a push mechanism (910-21) and a delivery sheath (910-22).
  11. 根据权利要求10所述实体瘤示踪装置,其特征在于:所述防移位机构(910-1)被设置在所述递送鞘管(910-22)内,所述推送机构(910-21)能将所述防移位机构(910-1)从所述递送鞘管(910-22)内推出置入实体瘤内。The solid tumor tracking device according to claim 10, characterized in that: the anti-displacement mechanism (910-1) is set in the delivery sheath (910-22), and the pushing mechanism (910-21 ) is capable of pushing the anti-displacement mechanism (910-1) out of the delivery sheath (910-22) into a solid tumor.
  12. 根据权利要求1所述实体瘤示踪装置,其特征在于:所述医用光学示踪系统(500)含光源(1)和光学示踪载体(2);The solid tumor tracing device according to claim 1, characterized in that: the medical optical tracing system (500) comprises a light source (1) and an optical tracing carrier (2);
    A、所述光学示踪载体(2)含导光材料;A, the optical tracer carrier (2) contains a light-guiding material;
    B、所述光源(1)发出的光经所述光学示踪载体(2)进行传导,并对所述光学示踪载体(2)进行光学示踪。B. The light emitted by the light source (1) is transmitted through the optical trace carrier (2), and the optical trace carrier (2) is optically traced.
  13. 根据权利要求12所述实体瘤示踪装置,其特征在于:所述光源(1)是LED光源(11)、和/或医用冷光源(12)、和/或自然光。The solid tumor tracking device according to claim 12, characterized in that: the light source (1) is an LED light source (11), and/or a medical cold light source (12), and/or natural light.
  14. 根据权利要求12所述医用光学示踪系统,其特征在于:所述光源(1)发出的光线的颜色可以根据背景颜色或穿透要求进行设置。The medical optical tracing system according to claim 12, characterized in that: the color of the light emitted by the light source (1) can be set according to background color or penetration requirements.
  15. 根据权利要求12所述医用光学示踪系统,其特征在于:所述光源(1)是闪烁型发光。The medical optical tracing system according to claim 12, characterized in that: the light source (1) is a flashing light.
  16. 根据权利要求12所述医用光学示踪系统,其特征在于:所述光源(1)发出的光线的强度可以进行设置。The medical optical tracing system according to claim 12, characterized in that the intensity of the light emitted by the light source (1) can be set.
  17. 根据权利要求12所述实体瘤示踪装置,其特征在于:所述LED光源(11)设置在体内、和/或体外。The solid tumor tracking device according to claim 12, characterized in that: the LED light source (11) is set inside the body and/or outside the body.
  18. 根据权利要求12所述实体瘤示踪装置,其特征在于:所述光学示踪载体(2)是蓄光自发光示踪载体(21)。The solid tumor tracking device according to claim 12, characterized in that: the optical tracking carrier (2) is a light-storing self-luminous tracking carrier (21).
  19. 根据权利要求18所述实体瘤示踪装置,其特征在于:所述蓄光自发光示踪载体(21)含蓄光自发光体(21-1)和保护载体(21-2)。The solid tumor tracking device according to claim 18, characterized in that: the light-storage self-luminescence tracing carrier (21) includes a light-storage self-luminescence body (21-1) and a protection carrier (21-2).
  20. 根据权利要求19所述实体瘤示踪装置,其特征在于:所述保护载体(21-2)由透明导光材料制成,所述蓄光自发光体(21-1)封闭设置在所述保护载体(21-2)内。The solid tumor tracking device according to claim 19, characterized in that: the protective carrier (21-2) is made of transparent light-guiding material, and the light-storing self-illuminating body (21-1) is closed and arranged on the protective Inside the carrier (21-2).
  21. 根据权利要求12所述实体瘤示踪装置,其特征在于:所述光学示踪载体(2)是导光光纤(22)。The solid tumor tracking device according to claim 12, characterized in that: the optical tracking carrier (2) is a light-guiding optical fiber (22).
  22. 根据权利要求21所述实体瘤示踪装置,其特征在于:所述导光光纤(22)具有非光滑的表面(22-1)。The solid tumor tracking device according to claim 21, characterized in that: the light guiding optical fiber (22) has a non-smooth surface (22-1).
  23. 根据权利要求22所述实体瘤示踪装置,其特征在于:所述非光滑的表面(22-1)是能形成反射、和/或散射的非光滑表面(22-11)The solid tumor tracking device according to claim 22, characterized in that: the non-smooth surface (22-1) is a non-smooth surface (22-11) capable of forming reflection and/or scattering
  24. 根据权利要求23所述实体瘤示踪装置,其特征在于:所述导光光纤(22)上间断式设置有出光口(22-2)。The solid tumor tracking device according to claim 23, characterized in that: the light-guiding optical fiber (22) is intermittently provided with light outlets (22-2).
  25. 根据权利要求24所述实体瘤示踪装置,其特征在于:所述导光光纤(22)编织成网状,不同位置散落状分布有出光口(22-2)。The solid tumor tracking device according to claim 24, characterized in that: the light guiding optical fiber (22) is woven into a net shape, and light outlets (22-2) are scattered in different positions.
  26. 根据权利要求12所述实体瘤示踪装置,其特征在于:所述导光光纤(22)表面含涂层(3)。The solid tumor tracking device according to claim 12, characterized in that: the surface of the light-guiding optical fiber (22) contains a coating (3).
  27. 根据权利要求21所述医用光学示踪系统,其特征在于:所述光学示踪载体(2)上设有显影机构(4),所述显影机构(4)在X光下、和/或MRI下、和/或B超下进行显 影。。According to the medical optical tracer system according to claim 21, it is characterized in that: the optical tracer carrier (2) is provided with a developing mechanism (4), and the developing mechanism (4) is under X-ray and/or MRI Under, and/or under the B ultrasound for development. .
  28. 根据权利要求1所述医用光学示踪系统,其特征在于:所述光学示踪载体(2)由柔顺的医用材料制成,设置在所述防移位机构(910-1)的外表面。The medical optical tracer system according to claim 1, characterized in that: the optical tracer carrier (2) is made of compliant medical material, and is arranged on the outer surface of the anti-displacement mechanism (910-1).
  29. 根据权利要求1所述实体瘤示踪装置,其特征在于:所述光学示踪载体(2)是导光光纤(22),所述导光光纤(22)的近端与导光接头(26)连接,所述导光光纤(22)的远端连接、固定在所述防移位机构(910-1)上,所述导光光纤(22)的出光口(22-2)设置在所述防移位机构(910-1)上,对所述防移位机构(910-1)进行示踪。The solid tumor tracking device according to claim 1, characterized in that: the optical tracking carrier (2) is a light-guiding optical fiber (22), and the proximal end of the light-guiding optical fiber (22) is connected to the light-guiding joint (26 ) connection, the far end of the light guiding fiber (22) is connected and fixed on the anti-displacement mechanism (910-1), and the light outlet (22-2) of the light guiding fiber (22) is set on the On the anti-displacement mechanism (910-1), trace the anti-displacement mechanism (910-1).
  30. 根据权利要求29所述实体瘤示踪装置,其特征在于:所述导光光纤(22)具有非光滑的表面(22-1),所述导光光纤(22)的侧面设有出光口(22-2),所述导光光纤(22)对所述防移位机构(910-1)进行整体示踪。The solid tumor tracing device according to claim 29, characterized in that: the light guiding fiber (22) has a non-smooth surface (22-1), and the side of the light guiding fiber (22) is provided with a light outlet ( 22-2), the light guiding optical fiber (22) traces the anti-displacement mechanism (910-1) as a whole.
  31. 根据权利要求30所述实体瘤示踪装置,其特征在于:所述导光光纤(22)由柔顺的医用材料制成,连接固定在所述防移位机构(910-1)上,当所述防移位机构(910-1)发生变形时,所述导光光纤(22)随着所述防移位机构(910-1)发生变形。The solid tumor tracking device according to claim 30, characterized in that: the light-guiding optical fiber (22) is made of flexible medical material, connected and fixed on the anti-displacement mechanism (910-1), when the When the anti-displacement mechanism (910-1) deforms, the light guide fiber (22) deforms along with the anti-displacement mechanism (910-1).
  32. 根据权利要求1所述实体瘤示踪装置,其特征在于:所述医用光学示踪系统(500)的光源(1)是LED光源(11),所述光学示踪载体(2)由透明材料制成,所述LED光源(11)的发光端(11-1)设置在所述光学示踪载体(2)上,与所述光学示踪载体(2)一起设置在所述防移位机构(910-1)上或所述防移位机构(910-1)上,对所述防移位机构(910-1)进行示踪。The solid tumor tracking device according to claim 1, characterized in that: the light source (1) of the medical optical tracking system (500) is an LED light source (11), and the optical tracking carrier (2) is made of a transparent material The light-emitting end (11-1) of the LED light source (11) is arranged on the optical trace carrier (2), and is arranged on the anti-displacement mechanism together with the optical trace carrier (2) (910-1) or on the anti-displacement mechanism (910-1), trace the anti-displacement mechanism (910-1).
  33. 根据权利要求32所述实体瘤示踪装置,其特征在于:所述LED光源(11)含发光端(11-1)、电路系统(11-2)、驱动板(11-3)和电源(11-4);所述发光端(11-1)通过所述电路系统(11-2)和所述驱动板(11-3)及所述电源(11-4)连接,在所述驱动板(11-3)的控制下,所述电源(11-4)通过所述电路系统(11-2)对所述发光端(11-1)供电,所述发光端(11-1)发出光线;所述驱动板(11-3)及所述电源(11-4)设置在体外,所述发光端(11-1)设置在体内,对所述防移位机构(910-1)进行示踪。The solid tumor tracing device according to claim 32, characterized in that: the LED light source (11) includes a light-emitting terminal (11-1), a circuit system (11-2), a driving board (11-3) and a power supply ( 11-4); the light-emitting terminal (11-1) is connected to the drive board (11-3) and the power supply (11-4) through the circuit system (11-2), and the drive board Under the control of (11-3), the power supply (11-4) supplies power to the light-emitting terminal (11-1) through the circuit system (11-2), and the light-emitting terminal (11-1) emits light ; The driving board (11-3) and the power supply (11-4) are arranged outside the body, and the light-emitting terminal (11-1) is arranged inside the body to show the anti-displacement mechanism (910-1) trace.
  34. 根据权利要求33所述实体瘤示踪装置,其特征在于:所述电路系统(11-2)是柔性电路板(11-21),所述LED光源(11)的发光端(11-1)分散设置在所述柔性电路板(11-21)上并封装在所述光学示踪载体(2)内,构成LED灯带、或LED灯网、或LED灯球,设置在所述防移位机构(910-1)上,对所述防移位机构(910-1)进行示踪。The solid tumor tracking device according to claim 33, characterized in that: the circuit system (11-2) is a flexible circuit board (11-21), and the light emitting end (11-1) of the LED light source (11) Dispersed on the flexible circuit board (11-21) and packaged in the optical tracer carrier (2), forming an LED light strip, or LED light net, or LED light ball, arranged on the anti-displacement On the mechanism (910-1), trace the anti-displacement mechanism (910-1).
  35. 根据权利要求29所述实体瘤示踪装置,其特征在于:所述LED光源(11)的发光端(11-1)设置在所述防移位机构(910-1)上,外部包覆透明材料制成的所述光学示踪载体(2),所述发光端(11-1)发出的光线对所述防移位机构(910-1)进行示踪。The solid tumor tracking device according to claim 29, characterized in that: the light-emitting end (11-1) of the LED light source (11) is set on the anti-displacement mechanism (910-1), and the outer coating is transparent The optical tracking carrier (2) is made of material, and the light emitted from the light-emitting end (11-1) tracks the anti-displacement mechanism (910-1).
  36. 根据权利要求31所述实体瘤示踪装置,其特征在于:所述发光端(11-1)分散地 设置在所述防移位机构(910-1)上,对所述防移位机构(910-1)进行整体示踪。The solid tumor tracking device according to claim 31, characterized in that: the light-emitting ends (11-1) are dispersedly arranged on the anti-displacement mechanism (910-1), and the anti-displacement mechanism ( 910-1) for overall tracing.
  37. 根据权利要求36所述实体瘤示踪装置,其特征在于:所述电路系统(11-2)是柔性电路板(11-21),所述光学示踪载体(2)由柔软的透明材料制成,所述发光端(11-1)、所述柔性电路板(11-21)和显影机构(4)一起设置在所述光学示踪载体(2)内,并设置在所述防移位机构(910-1)上,当所述防移位机构(910-1)发生变形时,所述发光端(11-1)、所述柔性电路板(11-21)、所述显影机构(4)和所述光学示踪载体(2)一起随着所述防移位机构(910-1)发生变形。The solid tumor tracking device according to claim 36, characterized in that: the circuit system (11-2) is a flexible circuit board (11-21), and the optical tracking carrier (2) is made of soft transparent material In this way, the light-emitting end (11-1), the flexible circuit board (11-21) and the developing mechanism (4) are arranged together in the optical tracer carrier (2), and arranged on the anti-displacement mechanism (910-1), when the anti-displacement mechanism (910-1) deforms, the light emitting end (11-1), the flexible circuit board (11-21), the developing mechanism ( 4) deform together with the optical tracking carrier (2) along with the anti-displacement mechanism (910-1).
PCT/CN2022/133695 2021-12-10 2022-11-23 Solid tumor tracing device WO2023103772A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111510039.4A CN116250942A (en) 2021-12-10 2021-12-10 Solid tumor tracer
CN202111510039.4 2021-12-10

Publications (1)

Publication Number Publication Date
WO2023103772A1 true WO2023103772A1 (en) 2023-06-15

Family

ID=86681409

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/133695 WO2023103772A1 (en) 2021-12-10 2022-11-23 Solid tumor tracing device

Country Status (2)

Country Link
CN (1) CN116250942A (en)
WO (1) WO2023103772A1 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5131380A (en) * 1991-06-13 1992-07-21 Heller Richard M Softwall medical tube with fiberoptic light conductor therein and method of use
WO1999064099A1 (en) * 1998-06-09 1999-12-16 Cardeon Corporation Cardiovascular catheter apparatus and catheter positioning method using tissue transillumination
WO2009050667A1 (en) * 2007-10-18 2009-04-23 Koninklijke Philips Electronics N.V. Tumor demarcation using targeted fluorescent probe and photonic needle
CN201350092Y (en) * 2009-02-13 2009-11-25 王宏飞 Light guide vein hook
CN102319120A (en) * 2011-09-13 2012-01-18 韩继武 Luminous body locating device for locating and incising focus parts
CN202569152U (en) * 2012-06-06 2012-12-05 马小鹏 Luminous positioning guide wire
US20150031987A1 (en) * 2013-07-24 2015-01-29 Cook Medical Technologies Llc Locating device
CN204863412U (en) * 2015-08-14 2015-12-16 宁波胜杰康生物科技有限公司 Novel lung neoplasm pilot pin
CN209932705U (en) * 2019-04-10 2020-01-14 潘艳丰 Luminous body device with fluorescence luminous function

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5131380A (en) * 1991-06-13 1992-07-21 Heller Richard M Softwall medical tube with fiberoptic light conductor therein and method of use
WO1999064099A1 (en) * 1998-06-09 1999-12-16 Cardeon Corporation Cardiovascular catheter apparatus and catheter positioning method using tissue transillumination
WO2009050667A1 (en) * 2007-10-18 2009-04-23 Koninklijke Philips Electronics N.V. Tumor demarcation using targeted fluorescent probe and photonic needle
CN201350092Y (en) * 2009-02-13 2009-11-25 王宏飞 Light guide vein hook
CN102319120A (en) * 2011-09-13 2012-01-18 韩继武 Luminous body locating device for locating and incising focus parts
CN202569152U (en) * 2012-06-06 2012-12-05 马小鹏 Luminous positioning guide wire
US20150031987A1 (en) * 2013-07-24 2015-01-29 Cook Medical Technologies Llc Locating device
CN204863412U (en) * 2015-08-14 2015-12-16 宁波胜杰康生物科技有限公司 Novel lung neoplasm pilot pin
CN209932705U (en) * 2019-04-10 2020-01-14 潘艳丰 Luminous body device with fluorescence luminous function

Also Published As

Publication number Publication date
CN116250942A (en) 2023-06-13

Similar Documents

Publication Publication Date Title
JP3868050B2 (en) Endoscope
US20050065496A1 (en) Chemiluminescently illuminated suction appliances
US20050099824A1 (en) Methods and systems for medical lighting
CN103379871A (en) User feedback through end effector of surgical instrument
US20100030033A1 (en) Surgical light apparatus
US20050251119A1 (en) Illuminated stylet
JP2009502215A (en) Method and apparatus for irradiating, observing and monitoring a body cavity
EP3720398B1 (en) Illuminated cannula
US20160184046A1 (en) Surgical tool lights
JP7267676B2 (en) lighting equipment
JP2022516171A (en) Positioning of the tube in the lumen by transillumination
CN105555183A (en) Medical device
WO2023103772A1 (en) Solid tumor tracing device
JP4253663B2 (en) Endoscope
US5624432A (en) Illuminating bougie and methods for diagnostic, therapeutic and surgical procedures
CN218128779U (en) Solid tumor tracer
WO2023103771A1 (en) Medical optical tracing system
KR101163630B1 (en) Location surgery luminaries capsules
CN218391285U (en) Medical optical tracing system
EP3827781A1 (en) Surgical instruments with integrated lighting systems
WO2023103781A1 (en) Optical fiber mechanism for medical optical tracing, and medical optical tracing system
CN217886229U (en) Optical fiber mechanism for medical optical tracing and medical optical tracing system
KR20070000408U (en) The structure of Auvard Weighted Speculum adapted LED light with contamination prevention function
TWI418328B (en) And a lateral light-emitting device engageable with the medullary needle
JP2021069801A (en) Medical marker

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22903195

Country of ref document: EP

Kind code of ref document: A1